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INTRODUCTION
The U.S. Food and Drug Administration (FDA), under the Federal
Food, Drug and Cosmetic Act,2 is not permitted to review the
ingredients in cosmetics before they are made available to the public
and has no authority to recall dangerous products. The FDA's
authority over recalls is limited to monitoring their effectiveness and
issuing press releases.3 Similarly, under the Toxic Substances
Control Act (TSCA), 4 the Environmental Protection Agency (EPA)
lacks the ability to compel cosmetics companies to demonstrate their
products are safe.s
The cosmetics industry opposes stringent pre-market federal
government oversight, instead touting its self-regulation system and
The authors would like to extend a very special thanks to Jessica Boffa, who was
invaluable as an editor, and Professor Elizabeth Cooper, who mentored us
throughout the writing process. This Note arose out of a partnership with WE ACT
for Environmental Justice, a non-profit, community-based group located in
Northern Manhattan whose mission is to build healthy communities by assuring
that people of color and/or low-income communities participate meaningfully in
the creation of sound and fair environmental health and protection policies and
practices. WE ACT FOR ENVTL. JUSTICE, http://www.weact.org (last visited
Dec. 11, 2011). The authors of this report served as legal interns for WE ACT
through Fordham University School of Law's Urban Policy and Legislative
Advocacy Clinic, Lincoln Square Legal Services, Inc.
2. Federal Food Drug and Cosmetic Act, 21 U.S.C. §§ 301-399a (2010).
3. Roseann B. Termini & Leah Tressler, American Beauty: An Analytical View
of the Past and Current Effectiveness of Cosimetic Safety Regulations and Future
Direction, 63 FOOD & DRUG L. J. 257, 271-72 (2008).
4. Toxic Substances Control Act, 15 U.S.C. §§ 2601-2692 (2010).
5. Id. at § 2602.
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supporting only mild increases in federal oversight.6 Despite claims
that its products are safe, the industry's review board, the Cosmetic
Ingredient Review (CIR) panel, as of 2005 had not assessed the
safety of 89% of the ingredients in personal care products. When
the CIR does review ingredients, it generally focuses on the
ingredients' potential to cause short-term dennatological reactions
such as rashes and eye irritation, not their potential to cause long-
term health problems such as cancer or reproductive harm.8
Part I of this Report lays out the factual background needed to fully
understand the need for greater cosmetics regulation, as well as many
recent events that have sparked greater debate over the need for
regulation. Part II discusses the major federal statutes affecting the
regulation of cosmetics in the United States, including the Federal
Food, Drug and Cosmetic Act, the Fair Packaging and Labeling Act,
and the TSCA. Part III examines current proposals for refonning the
Federal Food Drug and Cosmetic Act and the TSCA. Part IV focuses
on the potential for enacting stronger state and local laws and
regulations concerning cosmetics in New York. Part V summarizes
the Report's conclusions and sets out a series of policy and
regulatory recommendations.
I. FACTUAL BACKGROUND
A. Recent Developments
Cosmetics regulation is particularly ripe for reform due to a
renewed focus on hazardous cosmetics in the media. 2010 saw a
number of high-profile and widely-covered news stories concerning
6. Statement by Lezlee Westine, President and CEO of the Personal Care
Products Council, in Response to the Safe Cosnetics Act of 2010, PERS. CARE
PRODS. COUNCIL (July 21, 2010), http:/iWww.personalcarecouncil.org/
newsroom/20100721a.
7. See FDA Warns Cosnetic Industry to Follow Law on Untested Ingredients,
ENVTL. WORKING GRP. (Mar. 2005), http://",www.ewg.org/node/8703. The
Environmental Working Group is a non-profit organization specializing in
educating consumers in matters involving public health and the environment. About
the Environmental Working Group, ENVTL. WORKING GRP., http:xxx/www.wcsg.org/
about (last visited Dec. 11, 2011).
8. STACY MALKAN, NOT JUST A PRETTY FACE - THE UGLY SIDE OF THE
BEAUTY INDUSTRY 11-12 (2007).
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the possible dangers posed by ingredients in cosmetics, as well as the
cultural pressures to use cosmetics. This section will examine some
of the events that have drawn increased attention to the need for
greater cosmetics regulation in the United States.
1. Brazilian Hair Straightening Treatments
In 2007, a hair treatment from Brazil swept into American salons,
promising to keep hair straight for four months, far longer than older
methods, all while improving hair health. The hair straightening
treatments utilize liquid keratin, a naturally occurring protein, and an
extremely hot iron to hydrate and relax hair.9 The treatment is now
extremely popular, available throughout the world, and costs from
$250 to $600.10 'hile many manufacturers knew that certain
formulas contained formaldehyde, a known human carcinogen, some
still contended that the levels were safe.'
After receiving numerous complaints from salon workers suffering
from nosebleeds, eye irritation, and breathing problems after
applying Brazilian hair straightening treatments, the Oregon
Occupational Safety and Health Agency (OSHA) began investigating
the hair solution in early 2010.12 A report by the Oregon Health and
Science University's Center for Research on Occupational and
Environmental Toxicology revealed potentially unsafe levels of
formaldehyde in Brazilian Blowout, a brand of Brazilian hair
straighteners.13 Oregon OSHA also conducted tests on another brand
of Brazilian straightener, Agai Professional Hair Smoothing Solution,
which found levels of formaldehyde as high as 100 times those
9. Elizabeth Hayt, Curls, Split! Ringlets, Be Gone!, N.Y. TIMES, July 19, 2007,
at G3.
10. Id.; Courtney Perkes, State Sues Adakers of Brazilian Blowout; Officials Say
Hair Treatment is Unsafe, ORANGE COUNTY REG., Nov. 17, 2010, at E3.
11. Terry Pristin, A Safety Kink in Hlair Relaxing?, N.Y. TIMES, Nov. 4, 2010, at
E3.
12. KERMIT MCCARTHY ET AL., OREGON OCCUPATIONAL SAFETY AND HEALTH
ADMINISTRATION & OREGON HEALTH & SCIENCES UNIVERSITY'S CENTER FOR
RESEARCH ON OCCUPATIONAL AND ENVIRONMENTAL TOXICOLOGY, KERATIN-
BASED HAIR SMOOTHING PRODUCTS AND THE PRESENCE OF FORkLDEHYDE
(October 29, 2010).
13. Molly Prior & Andrea Nagel, Salon Industry Grapples with Fallout from
Blowout, WOMEN'S WEAR DAILY, Oct. 8, 2010, at 6.
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deemed safe by the United States OSHA.14 Oregon Congressional
Representative Earl Blumenauer has asked the FDA and the Federal
Trade Cormnission to investigate whether Brazilian Blowout and
Agai Professional Smoothing Solution pose safety risks to consumers
and whether the products are properly labeled.' 5
The impact of the investigation extends far beyond Oregon's
borders: in October 2010, Canada's public health department issued a
warning to consumers not to use Brazilian Blowout,' 6 and England
and Ireland have issued recalls for both Brazilian Blowout and Agai
Professional Smoothing Solution.' 7 In November 2010, California's
Attorney General filed suit against GIB, the manufacturer of
Brazilian Blowout, for failure to disclose unsafe levels of
formaldehyde and sought an injunction barring its sale.1
The suit also alleges GIB engaged in false advertising by asserting
that some of its products were "formaldehyde-free" and "salon
safe."19 On November 4, 2010, the Personal Care Products Council,
the trade association representing the cosmetics industry, announced
it was working with the FDA to review the use of formaldehyde in
professional hair smoothing products.20
The Brazilian Blowout controversy attracted the attention of the
United States OSHA and prompted the agency to issue a hazard alert
14. Jill U. Adams, A Closer Look; Brazilian Blowout Questions Continue, L.A.
TIMES, Nov. 29, 2010, at El.
15. Katy Muldoon, Blunenauer Asks Feds to hnestigate Hair-Care Products
with Formaldehyde, THE OREGONIAN, Oct. 6, 2010, available at
http://xwww.oregonlive.com/health/index.ssf 2010/10/blumenauer asks feds to in
vest.html.
16. Carly Weeks, With Hair Products, It's Buyer Beware: It Took Conplaints
From Consumers Before Health Canada Issued Warning about Brazilian Blowout,
GLOBE & MAIL, Oct. 19, 2010, at L4.
17. Health Briefing, IRISH TIMES, Oct. 19, 2010, at 2.
18. Andrea Nagel, California Sues Brazilian Blowout, WOMEN'S WEAR DAILY,
Nov. 12, 2010, available at http:/'xxwww.wwd.com/beauty-industry-
news?module=tn#/article/beauty-industry-news/california-sues-brazilian-blowout-
3380901.
19. Adams, supra note 14.
20. Statement by John Bailey, Chief Scientist, Personal Care Products Council:
Industry Concerned About Safety of Ingredient in Professional Hair Smoothing
Products, PERS. CARE PRODS. COUNCIL (Nov. 4, 2010), available at
http://"'www.ctfa.org/newsroom/20101104.
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to salon owners and workers in April 2011.21 OSHA's investigations
found levels of formaldehyde that exceeded the safe level for salons,
even among products purporting to be free of the chemical.22 The
agency recormmended salons cease use of products containing
formaldehyde due to dangers such as eye and nose irritation, skin
reactions, and the link between fonnaldehyde and nose and lung
23cancers.
2. "I Love My Hair"
In 2010. Sesame Street struck a chord with African-American
woman and girls across the country and drew considerable attention
to the debate regarding chemically straightening ethnic hair,
particularly for young girls. In a segment titled "I Love My Hair," a
female African-American Muppet sings about her natural hair and
the variety of styles it allows her to wear.24 The clip not only made
an impact on TV audiences, but also became a viral success -
logging over 2.8 million views on YouTube.com as of October
2011 .25 The show's head writer, Joseph Mazzarino, was inspired by
Chris Rock's documentary on the black hair products industry, Good
Hair, and his young Ethiopian-born daughter's preference for
straight, Western hair.26
3. "Fierce" Fragrance Protests
Popular teen clothing store Abercrombie & Fitch received
unwanted attention in 2010 for use of potentially dangerous
chemicals. Teens Turning Green, a student group advocating
21. US Labor Department's 'OSH4 issues hazard alert to hair salon owners,
workers on smoothing and straightening products that could release formaldehyde,
DEPT. OF LABOR (Apr. 11, 2011), http://xwww.osha.gov pis/oshaweb/
owadisp.show document?p table=NEWSRELEASES&p id=19584.
22. Id.
23. Id.
24. Alene Dawson, The Hair Issue: Rewriting the Rules, L.A. TIMES, Oct. 31,
2010, at 6.
25. Sesame Street:Song: I Love Ady Hair, YouTUBE (Oct 12, 2010),
http://" www.youtube.com/xwatch?v=enpFde5rgmw.
26. Kyle Buchanan, Sesane Street's Head Writer Explains the Show's V'iral-
Video Dominance, N.Y. MAG. VULTURE BLOG (Oct. 21, 2010), http://nymag.com/
daily/entertainment/2010/10/sesame streets head writer exp.html.
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environmentally responsible choices, alleges the chain is harming the
environment and their customers' health by automatically spraying
its cologne, Fierce, from store track lighting. 27 Following testing of
the fragrance, the Campaign for Safe Cosmetics, a coalition of
organizations promoting cosmetics reform, announced that Fierce
contains eleven ingredients not disclosed on the label, including those
known to cause allergic reactions and disrupt hormones.28 Teens
Turning Green staged protests at Abercrombie & Fitch stores in
California and New York in October 2010, hoping to draw attention
to the problem and convince the chain to cease use of the fragrance in
their stores.29
B. Products and Chemicals ofPossible Concern
There are a number of ingredients commonly found in cosmetic
products that raise serious health threats. According to a study by the
Environmental Working Group,30 more than half of cosmetic
products contain chemicals that can act like estrogen, disrupting the
body's natural hormone balance.3' Endocrine-disrupting chemicals
are particularly concerning because they are so widespread in the
environment.32 One study by the United States Department of
27. Grace Gold, Abercrombie & Fitch Under Fire For Spraying Cologne
Containing 'Secret Chenicals' in Stores, STYLELIST (Oct. 28, 2010),
http://xxwww.stylelist.com/2010/10/28/abercrombie-and-fitch-fragrance-protest-
teens.
28. Id.
29. See Perfume Protest: Teens Storm 'Toxic' Abercrombie & Fitch, TIME
NEWSFEED (Oct. 10, 2010), http: /newsfeed.time.com/201 10/ 04/perfume-protest-
teens-strom-%E2%80%98toxicE2%80%99-abercrombie-fitch; Gold, supra note
27.
30. Jane Houlihan, Why This Adatters: Cosmetics and your Health, ENVTL.
WORKING GRP. (2011), http:/'xwww.ewg.org/skindeep/2011/04/13/why-this-
matters/ (last visited Dec. 11, 2011).'
31. See What You Should Know About Chemicals in Your Cosnetics,
CONSUMER REPORTS SHOPSMART, Jan. 2007, at 8, available at
http://"x xwww.consumerreports.org/cro.promos/shopping/shopsmarti/Winter-
2007/x"what-you-should-know-about-chemicals-in-your-
cosmetics/overview/i0701 cosmetics ov.htm.
32. Rachel Rawlins, Teething on Toxins: In Search of Regulatory Solutions for
Toys and Cosnetics, 20 FORDHAM ENVTL. L. REv. 1, 3 (2009).
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Interior revealed a high incidence of intersex smallmouth bass 3 in
the Potomac River Basin, along with chemicals from pesticides,
flame-retardants, and personal-care products that are known or
suspected endocrine disruptors.34 The intersex condition in fish is
caused by hormone disruption, and joins a growing body of evidence
suggesting similar conditions in other animals including birds,
mammals, and humans.35 This and other studies have established
that endocrine disruptors can cause intersex in fish. * However,
further study is needed to detennine the precise environmental
factors and mechanisms, including the presence of endocrine
disruptors that contribute to intersex in these species.37
The lax regulation of cosmetic products causes serious concern not
only because of the potential to harm all users, but also because of
the particular danger they may pose to women of reproductive age
and children.38 A pregnant woman shares exposure to toxicants in
the blood with her developing fetus, which may experience larger
doses of the toxicant relative to its body weight.39 Additionally, as
toxicants may stay in the body long after initial exposure, a fetus can
be harmed even though the material is no longer in the woman's
body.40  One study found an aerage of 200 different industrial
chemicals or pollutants in the umbilical cord blood of ten babies.41
Because children are especially susceptible to many environmental
risks, exposure to chemicals from conception through adolescence
33. Blazer et al., Intersex (Testicular Oocytes) in Smtallmouth Bass from the
Potomac River and Selected Nearby Drainages, 19 J. AQUATIC ANIMAL HEALTH
242 (2007).
34. Id. at 250.
35. Emily Sohn, More Hermaphrodite Fish in U.S. Rivers, DisCOVERY NEWS
(Sept. 15, 2009), http://news.discovery.com/animals/more-hermaphrodite-fish-in-
us.html.
36. See Jo Ellen Hinck et al., Widespread Occurrence of Intersex in Black
Basses (Micropterus Spp.) from US. Rivers, 1995-2004, 95 AQUATIc TOXICOLOGY
60, 61, 68-69 (2009).
37. Id. at 69.
38. Rawlins, supra note 32, at 2.
39. Id.
40. Id. at 2, 6.
41. Id.
2011] 209
210 FORDHAM ENV7RONMENTAL LAW REVIEW
can lead to a lifetime of functional deficits and increased disease
risks.42
1. Phthalates: An Example of Dangerous Chemicals Found in
Cosmetics
A chemical may be of particular concern because of its ubiquity,
its high toxicity, or both. One such example is phthalate.43 Phthalate
exposure occurs by breathing in air containing phthalate vapors or
through the skin.44 Ihile phthalates are most commonly associated
with products such as vinyl floors, shower curtains, and plastic
dinnerware, they are also used in a number of personal care products
such as shampoo, nail polish, and hair spray. 45
In 2000, the Centers for Disease Control and Prevention (CDC)
found phthalates in a wide variety of cosmetics, many of which did
not include the chemical in their ingredient lists.46 CDC researchers
have found widespread phthalate exposure in the United States
population, with adult women showing higher levels of phthalates
metabolites, the breakdown product resulting from phthalates
entering the body, used in personal care products.47 Young children
may be especially vulnerable to exposure due to hand-to-mouth
behaviors.48
Evidence continues to mount that phthalates in any form are
harmful, particularly to fetuses and infants. Dibutyl phthalate (DBP),
a phthalate found in a variety of personal care products, causes
serious birth defects and even death in laboratory animals exposed to
42. Id.
43. National Report on Human Exposure to Environmental Chemicals:
Phthalates Fact Sheet, CTRS. FOR DISEASE CONTROL, 1 (Nov. 2009),
http:./xwww.cdc.gov/exposurereport/pdflPthalates FactSheet.pdf (defining a
Phthalate as an industrial chemical that acts as a "plasticizer," increasing the
plasticity or fluidity of a material).
44. Id.
45. Id.
46. Malkan, supra note 8, at 16 (citing B.C. Blount et al., Levels of Seven
Urinary Phthalates Metabolites in a Human Reference Population, 108 ENVIRON.
HEALTH PERSPECTIVES 979, 979-82 (Oct. 2000)).
47. National Report on Human Exposure to Environmental Chemicals:
Phthalates Fact Sheet, supra note 43.
48. As young children have a tendency to insert their hands into their mouths,
there is increased risk of ingesting harmful chemicals. Id.
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it during development.49  A 2005 study examined the effects of
prenatal phthalate exposure at the environmental level and discovered
"a significant relationship" between the levels of phithalates in human
women's bodies during pregnancy and adverse effects on male
reproductive development.50
Phthalates may also cause early puberty in girls, premature
delivery, decreased sperm quality and sperm damage, changes in
testosterone production, and testicular cancer.5 ' In the wake of such
research, California and New York have banned phthalates from
children's products.52 However, these bans do not include products
women may use during pregnancy, or any products not marketed
specifically to children that they would nevertheless surely encounter
in a household. And, while virtually all nail polish manufacturers
have removed DBP from their products sold in Europe and the
United States, DBP is still a component of many other cosmetics.54
2. Permanent Hair Relaxers
Nail polish, perfumes, and hair smoothing treatments are often the
subjects of media attention regarding the possible health risks
associated with chemicals in those products, but ethnic hair products
receive comparatively little attention. Many users of ethnic hair
49. DI-n-Butyl Phthalate, AGENCY FOR Toxic SUBSTANCES AND DISEASE
REGISTRY, 2 (Sept. 2001), http://x'www.atsdr.cdc.gov/tfactsl35.pdf.
50. Shanna H. Swan et al., Decrease in Anogenital Distance Among Male
Infants with Prenatal Phthalate Exposure, 113 ENVTL. HEALTH PERSPECTIVES
1056, 1056 (2005).
51. Rawlins, supra note 32, at 4.
52. Bette Hileman, California Bans Phthalates In Toys For Children, CHEM. &
ENG'G NEWS, Oct. 22, 2007, at 12; see also Bisphenol A-Free Children and Babies
Act, N.Y. ENVTL. CONSERv. LAW §§ 37-0501 to -0511 (McKinney 2010).
53. Household products containing phthalates that children are likely to
encounter include flooring, plastic wraps and food containers. See Bisphenol A-
Free Children and Babies Act, N.Y. ENVTL. CONSERv. LAW § 37-5303 (limiting the
deminuion of "child care product" to "all pacifiers and unfilled beverag
containers").
54. Following a ban of DBP in the European Union in 2004 and increased
negative press coverage of chemicals in nail polish in the United States, Proctor &
Gamble and Estee Lauder removed DBP from their worldwide nail polish
formulas. Later that year, Revlon, L'Oreal and Unilever followed suit. Malkan,
supra note 46, at 44, 50 (citations omitted).
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products lack an awareness of the dangers they pose, further
highlighting the need for a system of cosmetics regulation that is not
dependent on outcry in the media concerning a few particular
products.
There are immense cultural pressures from within and without the
Black community to conform to Western ideals of beauty. These
standards are often reinforced in school or work through dress codes
and appearance standards. 6 Since a federal district court upheld
American Airlines' decision to prohibit an African-American flight
attendant from wearing her hair in braids in order to conform to its
appearance policy, many corporations have embraced their power to
dictate standards of appearance that may prohibit "natural" ethnic
hairstyles. 7  Many in the Black community use hair relaxers for
much of their lives, and parents may begin using relaxers on their
children at a very young age. As a child's body is not able to
detoxify or eliminate chemicals as efficiently as an adult's, children
are particularly susceptible to their associated harms. 8
African-American women spend 80% more per capita than any
other ethnic groups on cosmetics.59 They spend double the amount
of other ethnic groups on hair treatments.60 The most ubiquitous of
these treatments is the permanent relaxer. Permanent relaxers, also
referred to as "perms" or "relaxers," use chemicals to straighten
naturally textured or curly hair.61 As new hair growth emerges, it
also requires treatment to maintain a uniform hair texture.
Retreatment is typically performed every six weeks, though some
55. See generally Angela Onwuachi-Willig, Another Hair Piece: Exploring
New Strands ofAnalysis under Title VII, 98 GEO. L.J. 1079 (2010).
56. See generally id.
57. Rogers v. Am. Airlines, 527 F. Supp. 229 (S.D.N.Y. 1981); see also Eatman
v. United Parcel Serv., 194 F. Supp. 2d 256, 259 (S.D.N.Y. 2002) (upholding UPS'
standards requiring employee to cover his Nubian locks with a company-issued
hat).
58. NAT'L. ACAD. OF SCIs., PESTICIDES IN THE DIETS OF INFANTS AND
CHILDREN 4 (1993).
59. Tracy Jones, No Matter How You Cut It, African-American Hlair Styling is
Big, FLA. TIMES-UNION (Nov. 7, 2010), http://jacksonville.com/entertainment/
2010-11-07/story/all-about-black-hair.
60. Id.
61. INGRID BANKS, HAIR MATTERS: BEAUTY, POWER AND BLACK WOMEN'S
CONSCIOUSNESS 172 (2000).
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may use the relaxers more or less frequently depending on personal
preference and hair growth speed. 2 Users can purchase professional
relaxer applications at salons or apply them at home using kits from
beauty supply stores or most drug stores.63 Manufacturers also
produce relaxers for children, which are widely available alongside
those marketed to adults.64 The children's relaxers contain the same
chemical agents used in adult products, but in weaker
concentrations.65 In addition to permanent relaxers, beauty supply
stores and drug stores carry conditioning products, designed for use
following permanent relaxer treatment, to soften the texture of the
treated hair.66
3. Possible Health Risks of Permanent Hair Relaxers
Even though permanent relaxers have been used for decades, they
present a number of serious health concerns. Traditionally they
contained lye, a corrosive form of sodium hydroxide, to break down
hair proteins and straighten the hair shaft. 7 Due to concerns over the
strength of sodium hydroxide and its ability to cause severe scalp
burns, it is now more common to see "no lye" relaxers in consumer
stores.6 "No lye" relaxers use a weaker chemical agent and thus are
less likely to cause injury to the scalp and hair damage, but tend to be
less effective.69
62. Tina Ezell Hull, Catching the Natural Wave: African American Women
Learning to Love Hair's Natural Texture, THE CHARLOTTE OBSERVER, 2,
http://documents.cms.kl2.nc.us/dsweb Get/Document-
17118/Catching%20the%2ONatural%2OWave.pdf (last viewed Dec. 11, 2011).
63. Id. On September 25, 2010, an author of this Report visited three beauty
supply stores and a drug store in midtown Manhattan along with La Vida Johnson,
a graduate of the University of Pennsylvania's Fels Institute of Government, who
has extensive experience with American-African salons and ethnic hair products.
They examined the ethnic hair sections at four stores in Manhattan, including three
independent stores and one large chain store.
64. See id.
65. See id.
66. See id.
67. Black Hair History, JAZMA HAIR INC., http:// ,www.jazma.com/black-hair-
history (last visited Dec. 11, 2011).
68. See id.
69. Id.
2011] 213
214 FORDHAM ENV7RONMENTAL LAW REVIEW
Despite this change, relaxers still contain a number of ingredients
that may pose serious health risks. According to an analysis by the
Enviromnental Working Group. 97% of hair straighteners contain
petrochemical ingredients that may be contaminated with 1,4-
dioxane, which the EPA has deemed a possible human carcinogen. 70
In addition to chemical compounds of concern, many ethnic hair
products, including conditioners paired with permanent relaxers,
contain hormones that pose danger. For example, placenta products
advertised as hair strengthening and conditioning may contain
71
estrogenic hormones linked to early puberty and breast cancer.
To ensure only safe cosmetic products reach consumers, it is
essential to understand the current regulatory regime. The next
section of this Note analyzes the federal statutes controlling
cosmetics in the United States, illustrates their inadequacies, and
highlights the need for legislative and regulatory reform.
II. COSMETIcs REGULATION AT THE FEDERAL LEVEL
Three statutes largely control cosmetics regulation in the United
States: the Federal Food, Drug and Cosmetic Act (FDCA),72 the Fair
Packaging and Labeling Act (FPLA),' and the TSCA.74 This section
will examine the histories and mechanics of these statutes, as well as
their deficiencies that permit dangerous cosmetic products to enter
the market and impede product removal.
70. EWG Research Shows 22 Percent of All Cosnetics May Be Contaminated
With Cancer-Causing Impurity, ENVTL. WORKING GRP. (Feb. 8, 2007),
http://"x xwww.ewg.org/release. ewg-research-shows-22-percent-all-cosmetics-may-be-
contaminated-cancer-causing-impurity. The EPA uses guidelines to categorize an
agent's potential as a human carcinogen. Human data, animal data and supporting
data are used to characterize the "weight-of-evidence" to classify an agent into one
of five groups. Agents in Group A are human carcinogens; Group B are probable
human carcinogens; Group C are possible human carcinogens; Group D are not
classifiable as to human carcinogencity; Group E evinces non-carcinogencity for
humans. Guidelines for Carcinogen Risk Assessment, 51 Fed. Reg. 33992-01
(Sep. 24, 1986). The chemical 1,4-Dioxane is classified by the EPA as a Group B
substance. 1,4-Dioxane (1, 4-Diethyleneoxide), DEP'T ENVTL. PROT.,
http://xxwww.epa.gov/ttn/atw/hithef dioxane.html (last updated Nov. 6, 2007).
71. Malkan, supra note 8, at 69.
72. See Federal Food Drug and Cosmetic Act, 21 U.S.C. §§ 301-399a (2010).
73. Fair Packaging and Labeling Act, 15 U.S.C. §§ 1451-1461 (2010).
74. See Toxic Substances Control Act, 15 U.S.C. §§ 2601-2692 (2010).
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A. The Federal Food, Drug and Cosmetic Act
The FDCA is the primary statute regulating cosmetics in the
United States. This section begins with an examination of the
historical events that led to the FDCA's inception, and then explains
how it currently controls the sale of cosmetics.
1. History of the Food, Drug and Cosmetic Act
During the Progressive Era , Congress was able to usher in
unprecedented regulation of private industry, yet the cosmetics
industry evaded federal oversight. The precursor to the modern
FDCA, the Pure Food and Drug Act,76 was passed in 1906, but
regulation of cosmetics was not included. This was partially due to
the minimal cosmetics market in the United States at the time.
During the 1930s, interest in regulating cosmetics began to rise
following a rash of publicity surrounding injurious cosmetics.
Koremlu, a depilatory (hair removal) cream that included a highly
toxic level of thallium acetate, drew attention in 1931 after users
began to suffer thallium acetate poisoning.79  Poisoning effects
include paralysis and nerve damage. Unfortunately, as Koremlu
was not classified as a drug under the Pure Food and Drug Act, the
FDA was powerless to act: private lawsuits also proved fruitless as
the manufacturer declared bankruptcy.8 Shortly after the Koremlu
scandal, the potential dangers of cosmetics once again made headline
news after a number of women became blind following the use of the
eyelash dye Lash Lure.82
75. The Progressive Era is generally defined as the period from 1890 to 1920.
The Progressive Era reformers in Congress succeeding in passing numerous
statutes aimed at increasing oversight to improve health and public welfare and to
eliminate corruption. See generally LEWIS L. GOULD, REFORM AND REGULATION:
AMERICAN POLITICS 1900-1916 (1978).
76. Pure Food and Drug Act of 1906, ch. 3915, 34 Stat. 768 (1906).
77. See Termini, supra note 3, at n.16, (citing Gary L. Yingling & Suzan Onel,
Cosmetic Regulation Revisited, 1 FUND. OF LAW & REG. 316 (1997)).
78. GWEN KAY, DYING TO BE BEAUTIFUL: THE FIGHT FOR SAFE COSMETICS 70-
72 (2005).
79. Id.
80. Id. at 70-71.
8 1. Id. at 7 1.
82. Id. at 72.
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While dangerous cosmetics continued to make headlines during the
193Os,8 Congress failed to enact proposed reforms of the Pure Food
and Drug Act that would bring cosmetics under the Act's purview,
despite support by President Franklin Delano Roosevelt. 4  The
proposed reform not only included regulation of cosmetics, but also
sought more stringent regulation of drugs. Though these refonns had
the backing of the FDA and the President, it took a devastating loss
of life to finally propel Congress into action. Over 100 people died
in 1937 after ingesting Elixir Sulfanilamide, a new "wonder drug"
purported to treat a variety of bacterial infections in adults and
children.85 The resulting public outcry prompted Congress to finally
address the refonn bills introduced in the wake of the Koremlu
scandal. In 1938 President Roosevelt signed the Federal FDCA into
law, not only addressing the problems which allowed for Elixir
Sulfanilamide to enter the market, but finally bringing the regulation
of cosmetics under the federal government's purview as well.86
2. Regulation under the Food, Drug and Cosmetic Act
The FDCA allocates authority to the FDA to regulate food, drugs,
medical devices and cosmetics.87 Under the FDCA, the FDA has the
authority to regulate all food products except meats and poultry
products, which the United States Department of Agriculture
oversees.88 The FDA may remove unsafe food from the market and
can require manufacturers of food additives to show that their
products will be safe. 89
Before a prescription drug can be sold in the United States, its
manufacturer must submit an application to the FDA containing
83. Id. at 76-78.
84. Termini, supra note 3, at 259.
85. Carol Ballentine, Taste of Raspberries, Taste qf Death: The 1937 Elixir
Sulfanilamide Incident, FDA CONSUMER MAG., June 1981, available at
http:// x xwww.fda.gov/AboutFDA/WH\atWeDo!History/ProductRegulation/Sulfanilai
ideDisaster/default.htm.
86. Termini, supra note 3, at 259.
87. See Federal Food Drug and Cosmetic Act, 21 U.S.C. §§ 301-399a (2010).
88. The FDA retains authority to regulate game meats such as venison, ostrich,
and snake. 21 U.S.C. § 321(f) (2010).
89. 21 U.S.C. § 348(c)(3)(A) (2010).
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information on the drug and testing conducted to verify its safety. 90
If the FDA's Center for Drug Evaluation and Research determines
that the drug's health benefits outweigh its known risks, it approves
the drug.91  Over-the-counter drugs must conform to FDA
"monographs" which specify acceptable "ingredients, doses,
formulations and labeling." 92
The FDA also has the authority to regulate medical devices,
including products used in the diagnosis, prevention, or treatment of
disease, or that affect the structure or any function of the body.9
Products classified as medical devices range from simple tongue
depressors to pacemakers. 94  If a device is not "substantially
equivalent" to an approved device, the manufacturer must submit an
application to the FDA and adhere to strict agency conditions before
it can market the device.95
The FDCA generally treats cosmetic products and their ingredients
very differently. The FDCA defines the term "cosmetic" as:
(1) articles intended to be rubbed, poured, sprinkled, or
sprayed on, introduced into, or otherwise applied to the
human body or any part thereof for cleansing, beautifying,
promoting attractiveness, or altering the appearance, and
(2) articles intended for use as a component of any such
articles; except that such term shall not include soap.96
Cosmetic products falling within the definition are:
skin moisturizers, perfumes, lipsticks, fingernail polishes,
eye and facial makeup preparations, shampoos, permanent
90. Id. § 355.
91. Approved Drugs: Questions and Answers, FOOD & DRUG ADMIN.,
http://www.fda.gov'Drugs/ResourcesForYou/Consumers/UCM054420 (last
updated Nov. 8, 2011).
92. Id.
93. 21 U.S.C. § 321(h) (2010).
94. What Does FDA Regulate?, FOOD & DRUG ADMIN.,
http://www.fda.gov/AboutFDA/Transparency/Basics/ucml94879.htm (last updated
Aug. 19, 2010).
95. 21 U.S.C. § 360(c), (o)(1)(A)-(C) (2010).
96. Id. § 32 1(i).
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waves, hair colors, toothpastes, and deodorants, as well as
any material intended for use as a component of a cosmetic
product.
Notwithstanding the FDA's broad authority to regulate food and
drugs, the agency has the authority to conduct pre-market testing
only of their color additives. 98  The FDA began to stringently
regulate and evaluate color additives following investigations during
the 1950s that found several previously approved color additives in
fact caused serious adverse health effects. 99 The FDA must now
approve color additives in FDCA-regulated products if the additives
will come into direct contact with the human body for a "significant
period of time."' 00 The FDA Commissioner publishes regulations
listing approved and restricted additives, as well as any conditions on
their use.10 If evidence suggests that an ingestible additive was the
causative substance in inducing cancer in humans or animals, the
Commissioner may ban its use.102 After a color additive is listed as
approved in an FDA regulation, it must also be batch certified before
it can be used in a product regulated under the FDCA.103 With the
exception of color additives, however, the FDA is unable to require
cosmetic manufacturers to file health and safety data on
97. Cosnetics Q&A: Cosmetics & Over-the-Counter Drugs, FOOD & DRUG
ADMIN., http://www.fda.gov/Cosmetics/ResourcesForYou/Consumers!
CosmeticsQA/ucml35712.htm (last updated June 18, 2009).
98. See, e.g., Toilet Goods Ass'n v. Finch, 419 F.2d 21 (2d Cir. 1969)
(explaining that 21 U.S.C. § 321 "scarcely show[s] that all finished cosmetics were
thought to be color additives requiring premarketing clearance"). Color additives
are defined as any dye, pigment or certain color-imparting substance used in food,
drugs and cosmetics. 21 U.S.C. § 321(t)(1) (2010).
99. Color Additives: FDA's Regulatory Process and Historical Perspectives,
FOOD & DRUG ADMIN., http:/ /www.fda.gov/Forlndustry/ColorAdditives!
RegulatoryProcessHistoricalPerspectives/default.htm (last updated Dec. 17, 2009).
100. 21 U.S.C. § 379(e) (2010).
101. Id.
102. 21 C.F.R. § 70.50 (2010).
103. Batch certification is the manner in which colors additives are certified with
the FDA. Color additive manufacturers submit a representative sample of their
color additive batch, which is reviewed to ensure it conforms with FDA
regulations. 21 U.S.C. § 379(e) (2010); 21 C.F.R. § 80.22 (2010).
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ingredients.104 Without this information, the FDA is not able to
determine the total possible harm a cosmetic product actually poses.
In fact, the FDCA pennits the FDA to take action only if there is
evidence that a cosmetic is "adulterated" or "misbranded.", 05
Adulterated cosmetics are those that may cause injury to users due to
contamination or because they contain hanful substances, while
misbranded cosmetics are those that are improperly or deceptively
labeled.'0o
Under the FDCA, a cosmetic is adulterated if:
(a) It bears or contains any poisonous or deleterious
substance which may render it injurious to users under the
conditions of use prescribed in the labeling thereof, or
under such conditions of use as are customary or usual ...
[coal-tar hair dyes with a prescribed warning are
exempted].
(b) It consists in whole or in part of any filthy, putrid, or
decomposed substance.
(c) It has been prepared, packed, or held under insanitary
conditions whereby it may have become contaminated with
filth, or whereby it may have been rendered injurious to
health.
(d)Its container is composed, in whole or in part, of any
poisonous or deleterious substance which may render the
contents injurious to health;
(e) It is not a hair dye and it is, or it bears or contains, a
color additive which is unsafe within the meaning of
section 379e(a) of this title.107
The FDA's ability to take action against misbranded products
stems from its authority under the FDCA to regulate the labeling of
104. 21 U.S.C. § 379(e) (2010).
105. See infra Part I.B. (discussing the FDA's authority over misbranded
products under Fair Packaging and Labeling Act); see also Cosmetics Q&A: FDA 's
Authority, supra note 97.
106. 21 U.S.C. § 379(e) (2010).
107. Id. § 361. The parameters for listing a color additive as unsafe, including
permitted exceptions, are found at 21 U.S.C. § 379e(a).
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cosmetics.1os Thus, FDA regulations require that every cosmetic
product display an ingredient declaration to enable consumers to
make informed purchasing decisions. 109  Under the FDCA, a
cosmetic is considered "misbranded" if:
its labeling is false or misleading in any particular;
its label does not include all required information
the required information is not adequately prominent and
conspicuous its container is so made, formed, or filled as to
be misleading:
it is a color additive, other than a hair dye, that does not
conform to applicable regulations;
its packaging or labeling is in violation of an applicable
regulation issued pursuant to the Poison Prevention
Packaging Act of 1970.110
Notwithstanding its technical ability to regulate cosmetics in this
manner, the FDA in fact has limited control over the sale of
adulterated or misbranded products. Most notably, the FDCA does
not permit the FDA to issue recalls for products."' The FDA has
also been reluctant to ban dangerous ingredients in cosmetics,
restricting or prohibiting the use of only nine such ingredients. 112 In
contrast, the European Union has banned more than 1,000 chemicals
known or suspected of causing cancer, genetic abnormalities, or birth
defects. 11
The FDA's inability to adequately address dangerous cosmetics is
abundantly clear when examining the agency's treatment of skin-
108. 21 U.S.C. § 362 (2010).
109. See id.
110. Id.; see also 15 U.S.C. §§ 1472-73 (2010).
111. Termini, supra note 3, at 271.
112. The banned ingredients are bithionol, mercury compounds, vinyl chloride,
halogenated salicylanilides, zirconium complexes in aerosol cosmetics, chloroform,
methylene chloride, and chlorofluorocarbon propellants. 21 C.F.R., §§ 250.250,
700.11 to .35 (2010).
113. Rawlins, supra note 32, at 20; see also infra Part III.A (discussing the
European Union's regulation of cosmetics).
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lightening creams.11 In 1990, the FDA banned mercury, a heavy
metal with the ability to lighten skin color, from skin care
products.1 15  By that point, the dangers of mercury were well
known.116 HWhile the ban by the FDA was clearly a step toward more
effective regulation and an accomplishment for the agency, its
effectiveness is questionable. In May 2010, an investigation by the
Chicago Tribune revealed that some skin lightening creams still
contained mercury, though the FDA had banned the ingredient from
skin lightening creams twenty years earlier. 117 An FDA
spokesperson responded that due to their small number of inspectors
"it is likely that things get past [the FDA].""' Further, the FDA's
lack of recall authority makes it virtually impossible to demand a
recall of these mercury-containing products. 11 It is likely that many
of these mercury-containing products remain on the market today.
In 2006, the FDA proposed a ban on use of hydroquinone in over-
the-counter skin-lightening products due to its carcinogenic risk and
potential to cause disfigurement.12 0 Since the FDA offered the rule
for notice and comment, however, it has not taken any further
action.121 Indeed, the agency's inability to effectively enforce its ban
114. Creams designed to lighten the skin may also be referred to as "skin
whitening" or "skin bleaching." See generally Imani Perry, Buying White Beauty,
12 CARDOZO J.L. & GENDER 579 (2006).
115. Leslie S. Baumann, Mercur}y, SKIN & ALLERGY NEWS, Sept. 1, 2010, at 28,
av'ailable at http:/ xxwww.skinandallergynews.comviews./cosmeceutical-critique-by-
leslie-s-baumann/'blog/mercurya2c3e53aa8.html.
116. Id.
117. Ellen Gabler & Sam Roe, Mercury Taints Some Skin Lighteners, CHI. TRIB.,
May 19, 2010, at 1.
118. Id.
119. See supra notes 3, 111 and accompanying text; see also infra Part III.B
(explaining that the proposed Safe Cosmetics Act of 2010 sought to give the FDA
authority to issue recalls).
120. Skin Bleaching Products For Over-the-Counter Human Use, 71 Fed. Reg.
51146 (proposed Aug. 29, 2006) (codified at 21 C.F.R. § 310).
121. Rulemaking History for OTC Skin Bleaching Drug Products, FOOD & DRUG
ADMIN., http: / x/www. fda.gov Drugs/DevelopmentApprovalProcess/
DevelopmentResources/Over-the-CounterOTCDrugs/StatusofOTCRulemakings!
ucm072117.htm (last updated Dec. 14, 2009).
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on mercury calls into question the worth of a ban by the agency and
highlights its lack of power.122
By contrast, the National Highway Traffic Safety Administration
(NHTSA) has the authority to issue recalls under the National Traffic
and Motor Vehicle Safety Act.123  If a vehicle or piece of motor
vehicle replacement equipment, such as tires, contains a safety-
related defect or does not comply with Federal Motor Vehicle Safety
Standards, the Secretary of Transportation can direct a manufacturer
to issue a recall. 124  If a company resists issuing a recall, the
Secretary can move to enforce a recall order in federal court, as well
as seek penalties.12 5 Often, the threat of a recall alone is enough to
lead a manufacturer to conduct its own investigation and issue a
recall voluntarily. 126
The Consumer Product Safety Commission (CPSC) has the similar
authority to force manufacturers to recall products that violate safety
standards.12 7 Because the CPSC's enabling statute, the Consumer
Products Safety Act, specifically excludes cosmetics, the agency is
not able to address unsafe cosmetics.128 Yet, aside from cosmetics
and a small number of products regulated by other federal agencies,
122. Additionally, many cosmetics manufacturers avoid testing their products'
ingredients for efficacy or, at least, avoid publicizing the results of such tests to
avoid having their products categorized as drugs. See Deborah E. Mason, Note,
Kiss and Adake-Uip: A Need for Consolidation of FDA and Cosmetic Industry
Regulation Programs, 18 HEALTH MATRIX 181, 182 (2008). These products often
contain ingredients that also are available in drugs. See id at 182-83. Questions
about whether these products are more appropriately categorized as drugs or as
cosmetics have led some commentators to call for the creation of a hybrid
"cosmeceutical" category of cosmetic products that claim to or have "been found to
have biologic activity." Id. Under this proposal, these products would be subject
to an intermediate level of premarket safety tests rather than the more extensive
testing required of drugs and the nonexistent testing currently in place for
cosmetics. See id. at 197.
123. National Traffic and Motor Vehicle Safety Act, 49 U.S.C. §§ 30101-30170
(2010).
124. Id. § 30118.
125. Id. § 30121.
126. See James C. Rathner, Jr., Total Recall, 58 LA. B.J. 102, 104 (Aug./Sept.
2010).
127. 15 U.S.C. § 2064 (2010); see also Consumer Products Safety Act, 15 U.S.C.
§§ 2051-2084 (2010).
128. Id. § 2052(a)(1)(H).
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the CPSC has wide authority to regulate nearly any product sold to
consumers for use in or around the household, or for entertainment or
personal use.129  The CPSC is also empowered to seek civil and
criminal penalties against violators. 1
Both the NHTSA and CPSC have successfully exercised their
recall powers for decades. Since the NHTSA was granted this
authority in 1966, the agency has recalled more than 390 million
vehicles.'1' The CPSC credits its regulation of consumer product
safety and recall efforts with contributing significantly to the 30
percent decline in the rate of deaths and injuries associated with
consumer products in the past 30 years.132
Absent an independent power of recall, the FDA may attempt to
remove adulterated and misbranded cosmetics from the market in
conjunction with the Department of Justice (DOJ) if consumer
complaints raise concerns about that product." For example, the
DOJ may go to federal court on behalf of the FDA to request a
restraining order preventing further shipment of an adulterated or
misbranded product, seize the product, or initiate criminal action
against violators.134
If a cosmetics manufacturer attempts to import a violative product
into the United States, the FDA has the power to refuse its entry into
interstate commerce.' 3 5  The United States Customs and Border
Protection (Customs) alerts the FDA when a product under its
purview arrives at a port of entry.136 If the FDA suspects a product
violates the FDCA, its owners are provided notice and afforded an
opportunity to introduce testimony regarding the admissibility of the
129. Id. § 2052(a)(1)(i)-(ii).
130. Id. §§ 2069-2070.
131. Motor Vehicle Safety Defects and Recalls Campaigns, NAT'L HIGHWAY
TRAFFIC SAFETY ADMIN., http://xwww.nhtsa.gov/Vehicle+Safety/
Recalls & Defects/Motor+Vehicle+Safety+Defects and+Recalls Campaigns
(last visited Oct. 28, 2011).
132. About CPSC, CONSUMER PROD. SAFETY COMM'N, http://www.cps.gov/
about/about.html (last updated Oct. 27, 2011).
133. Cosmetics Q&A: FDA's Authority, supra note 97.
134. Id.
135. FOOD & DRUG ADMIN., FDA REGULATORY PROCEDURES MANUAL, 9-2, 9-9
to 9-10, http://ww.fda.gov/ downloads/ICECI/ComplianceManuals/
RegulatoryProceduresManual/UCM074300.pdf (last revised Jan. 2008).
136. Id.
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product at an administrative hearing.137 If the FDA determines a
product violates the statute, Customs will issue a Notice of Refusal of
Admission and destroy any shipment that is not exported within 90
days. 138
In sum, although the FDA has some powers to prevent dangerous
products from entering the marketplace in the United States, the
agency's lack of recall capabilities is both troubling and indicative of
the inadequate cosmetics regulation regime in the United States. The
NHTSA's and CPSC's recall powers highlight the ability of the
federal government to effectively prevent unsafe products from
reaching consumers. Any future reform of federal statutes
controlling cosmetic regulation should look to the NHTSA and the
CPSC as models for recall capabilities.
3. Monitoring Mechanisms
The FDCA tasked the FDA with monitoring and enforcing the
statute, but the agency is not the only body monitoring cosmetics in
the United States. The cosmetics industry itself has implemented a
system of self-regulation and monitoring through the Cosmetic
Ingredient Review Panel. This section will review these agency and
industry monitoring mechanisms and their effectiveness.
a. The Office of Cosmetics and Colors
The Office of Cosmetics and Colors, a division of the Center for
Food Safety and Applied Nutrition (CFSAN), is the center within the
FDA charged with ensuring that cosmetic products are not
mislabeled or adulterated.139  In addition to issuing regulations
related to cosmetics and their labeling, the CFSAN is responsible for
overseeing research programs that address possible health risks
associated with chemical or biological contaminants, post-market
surveillance, consumer education and industry outreach.140 Despite
this robust mandate, as of 2007, the Office of Cosmetics and Colors
137. Id. at 9-30.
138. Id. at 9-36.
139. CFSAN - What We Do, FOOD & DRUG ADMIN., http://www.fda.gov/
AboutFDA/CentersOffices/CFSAN/WhatWeDo/default.htm (last visited Oct. 25,
2011).
140. Id.
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employed only 14 staff members and functioned with a budget of
only $3.5 million - a paltry sum considering the tens of billions of
dollars in cosmetics sales in the United States each year.141
Although the FDA's authority is limited to monitoring cosmetic
products already on the market, the Office of Cosmetics and Colors
does provide industry manufacturers, distributors and packagers with
"recommended draft guidances."1 42  These voluntary guidances are
designed to assist the cosmetics industry to develop systems that
decrease the likelihood of selling cosmetics that are adulterated,
misbranded, or both.
b. The Cosmetic Ingredient Review Panel
Congress has amended the FDCA numerous times since its passage
in 1938, but little has changed regarding the FDA's limited ability to
regulate cosmetics. Consumer and environmental groups repeatedly
have pressed for reform, and nearly succeeded in the 1970s.
In 1973, Senator Thomas Eagleton of Missouri proposed requiring
cosmetics manufacturers to perform thorough toxicology tests and
substantiate safety before they could sell their products to
consumers.144  Fearing sweeping change pressed upon it by
Congress, the Personal Care Products Council (PCPC),145 the
cosmetics industry's powerful lobby, decided to work with the FDA
to develop a system for monitoring cosmetic ingredients.146  The
industry lobby and the FDA agreed in 1976 to create the self-
monitoring Cosmetic Ingredient Review (CIR) panel in lieu of the
141. Peter Barton Hutt, The State of Science at the Food and Drug
Administration, 60 ADMIN. L. REV. 431, 461 (2008).
142. See, e.g., FOOD & DRUG ADMIN., FINAL GUIDANCE FOR INDUSTRY
COSMETICS PROCESSORS AND TRANSPORTERS: COSMETICS SECURITY
PREVENTATIVE MEASURES GUIDANCE, (Dec. 17, 2003), available at 2003 WL
24014301 (F.D.A.).
143. Id.
144. 119 CONG. REC. S4215-16 (daily ed. Feb. 15, 1973).
145. Known at the time as the Cosmetics and Fragrance Trade Association.
About Us, PERS. CARE PROD. COUNCIL, http://''www.ctfa.org/about-us/about-
personal-care-products-council (last visited Dec. 11, 2011).
146. See The Eagleton Bill, PERS. CARE PROD. COUNCIL,
http://www.personalcarecouncil.org/eagleton-bill (last visited Dec. 11, 2011).
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standardized toxicological testing proposed by Senator Eagleton.147
The CIR agreement allowed for "partial product labeling," which
required the cosmetics industry to identify ingredients in its products,
but created a loophole that allowed manufacturers to omit identifying
"trade secret" or "fragrance" ingredients. 148
The cosmetics industry funds and runs the CIR through the PCPC.
The CIR Expert Panel, which assesses safety data and makes final
decisions regarding the purported safety of an ingredient, has seven
voting members.149  The CIR's Steering Committee chooses voting
members from a list of scientists and physicians nominated by
outside groups, government agencies, and the cosmetics industry.'50
The PCPC, the FDA, and the Consumer Federation of America serve
as liaison representatives and non-voting members on the Expert
Panel.' 5 ' Although the CIR's ingredient and safety reviews are
designed to be open for public review, the trade secret and fragrance
exceptions ensure that a significant amount of information remains
unavailable to the FDA and the general public.152
B. Fair Packaging and Labeling Act
In addition to the FDCA, the FDA derives authority to regulate
cosmetics through the Fair Packaging and Labeling Act (FPLA).153
Congress initially passed the FPLA in 1966 to help consumers make
inforned purchasing decisions by requiring manufacturers to provide
accurate information on consumer goods packaging and labels.154
147. Id.
148. 21 C.F.R. §§ 701.3(a), 720.8 (2010); see also Malkan, supra note 8, at 103;
infra notes 157, 161-62, 164, 166 and accompanying text (defining "trade secret"
and "fragrance" and describing regulations controlling the exemptions).
149. How Does CIR Work?, COSMETIC INGREDIENT REV., http://www.cir-
safety. org/info.shtml (last visited Oct. 28, 2011).
150. COSMETIC INGREDIENT REV., COSMETIC INGREDIENT REVIEW PROCEDURES
6 (Oct. 2010).
151. Id. at 7.
152. See Robert L. Elder & Jonathon T. Busch, The Cosmetic Ingredient Review,
in THE COSMETIC INDUSTRY: SCIENTIFIC AND REGULATION FOUNDATIONS 203,
203-204 (Norman F. Estrin ed., 1984).
153. See Fair Packaging and Labeling Act, 15 U.S.C. §§ 1451-1461 (2010).
154. 15 U.S.C. § 1451 (2010). While the Federal Trade Commission is generally
charged with administering the provisions of the FPLA, the FDA retains the
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The statute generally requires that all consumer commodities bear a
label identifying the good, the name, place of business of the
manufacturer, and the net quantity of contents.
As the FDA began to work with the cosmetics industry to create a
system of self-regulation in the mid-1970s, 56  the agency
promulgated regulations under the FPLA requiring that ingredients in
cosmetic ingredients, with the notable exception of ingredients that
qualify as "trade secrets" or "fragrance," be identified by the name
established by the Commissioner of Food and Drugs.15 7
Though the FDCA contains provisions regarding misbranding, the
FDA's regulations promulgated under the FPLA expand the concept
of misbranding to factor in safety. 158 A product's safety is
adequately substantiated if qualified experts can "reasonably
conclude from the available toxicological and other test data,
chemical composition, and other pertinent information that the
product is not injurious to consumers under conditions of customary
use and reasonably foreseeable conditions of misuse." 1 9  If safety
has not been adequately substantiated, the product must include the
following conspicuous warning on a panel display: "Warning - The
safety of this product has not been determined."l60
The FPLA regulations contain an enormous loophole that may
allow manufacturers to include unsafe ingredients in products
without a warning label. If a chemical qualifies as a "trade secret" or
authority to promulgate regulations related to food, drugs and cosmetics controlled
by the FPLA. Id. § 1454(a).
155. Id. § 1453(a).
156. See supra Part II.A.3.b (discussing FDA's agreement with the cosmetics
industry to require only partial product labeling).
157. The Commissioner of Food and Drugs establishes name for cosmetics
ingredients in order to ensure uniformity among products. The Commissioner may
establish names upon request or by his or her own initiative. 21 C.F.R. §§
701.3(c), 720.8 (2010).
158. 15 U.S.C. § 1456(a) (2010).
159. Cosmetic Warning Statenents, FOOD & DRUG ADMIN.,
http:/'xwww.fda.gov/Cosmetics/CosmeticLabelingLabelClaims/CosmeticLabelingM
anual/ucml26444.htm#clgk (last updated July 29, 2011) (explaining the FDA's
interpretation of the requirements mandated by 21 C.F.R. § 740.10).
160. 21 C.F.R. § 740.10(a) (2010).
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is part of a "fragrance" or "coloring,"161 it is exempt from the
FPLA's ingredient identification requirements.' 62 The FDA considers
several factors when detennining whether an ingredient qualifies as a
trade secret: whether the identity of the ingredient is known outside
of the manufacturer's business; whether the identity of the ingredient
is known by employees of the manufacturers; the value of the trade
secret to competitors; the amount of effort or money spent to develop
the ingredient, and the ease or difficulty which with others could
acquire or duplicate the ingredient.163
The FDA defines the term "fragrance" as "any natural or synthetic
substance or substances used solely to impart an odor to a cosmetic
product."164 FDA regulations further require than an ingredient can
be labeled as a "fragrance" only if it is used in a manner consistent
with how consumers "commonly understand" the term.'65
If the FDA categorizes an ingredient as a trade secret or a
fragrance, the manufacturer may list "and other ingredients" in lieu
of the names of the exempted ingredients.1 66  The omission of
ingredient names from cosmetic product labels not only makes it
more difficult for consumers to make informed choices, but also may
make it easier for manufacturers to include ingredients that are
unsafe.
C. The Toxic Substances Control Act
The Toxic Substances Control Act (TSCA)16 7 was enacted in 1976.
Congress identified the statute's policy goals as follows:(1) to
161. See supra notes 148 and 152 and accompanying text; see also supra Part
II.A.2(discussing regulation of color additives).
162. 15 U.S.C. § 1454(c)(3)(B) (2010); 21 C.F.R. § 701.3(a) (2010); 21 C.F.R. §
20.61 (2010).
163. 21 C.F.R. § 720.8(b) (2010).
164. Id. § 700.3(d).
165. Id. § 701.3(a).
166. Id. § 701.3(a).
167. 15 U.S.C. §§ 2601-2692 (2010). TSCA is the only major piece of
environmental legislation enacted in the 1970s that has not been substantively
revised since it was passed, according to a report by the law firm of Beveridge and
Diamond, P.C. 1ARK N. DUVALL ET AL., BEVERIDGE & DIAMOND, P.C.,
PROPOSED LEGISLATION WOULD OVERHAUL TSCA (April 23, 2010),
http://swww.bdlaw.com/assets/attachments/2010-04-
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develop adequate data on the health and enviromnental effects of
chemical substances and mixtures while placing the onus on
manufacturers to develop this data;' 68 (2) to establish adequate
authority to regulate chemicals that present an unreasonable risk of
injury to health or the environment;169 and (3) to ensure that the
Environmental Protection Agency's regulatory authority balances the
aim of preventing unreasonable health and enviromnental risks with
concerns that such an authority could serve as an undue burden or
barrier to technological innovation. 70
Notwithstanding these broad goals, TSCA specifically exempts
cosmetics' 7 ' TSCA's definition of a chemical substance excludes
"any food, food additive, drug, cosmetic, or device (as such terms are
defined in section 201 of the Federal Food Drug and Cosmetic
Act)." 72 Dual-use chemicals may, however, be subject to TSCA for
non-cosmetic uses and to the FDCA when contained in a cosmetic.1
For example, phthalates used in non-exempt products, such as toys or
cleaning supplies, would be subject to the EPA's authority under
TSCA. 174 Phthalates used in a cosmetic product, however would
remain subject to the FDA's authority under the FDCA.171
Because the FDCA broadly defines the term cosmetic to include
"articles intended for use as a component of" a cosmetic product,176
19%20Alert%20on%20Proposed%2OLegislation%20to%200verhaul%20TSCA.pd
168. 15 U.S.C. § 260 1(b)(1) (2010).
169. Id § 2601(b)(2).
170. Id § 2601(b)(3).
171. Id § 2602(2)(B)(vi).
172. Id Under the FDCA:
(i) The term 'cosmetic' means (1) articles intended to be rubbed,
poured, sprinkled, or sprayed on, introduced into, or otherwise
applied to the human body or any part thereof for cleansing,
beautifying, promoting attractiveness, or altering the appearance, and
(2) articles intended for use as a component of any such articles;
except that such term shall not include soap.
21 U.S.C. § 321(i) (2010).
173. LYNN L. BERGESON, TSCA: THE Toxic SUBSTANCES CONTROL ACT 4
(2000).
174. See id (describing a similar example involving the Federal Insecticide,
Fungicide, and Rodenticide Act (FIFRA) and TSCA).
175. Id.
176. 21 U.S.C. § 321(i)(2) (2010).
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the raw materials, intermediates, and catalysts intended solely for use
in cosmetics are excluded from TSCA regulation.' 7 7  Yet this
exemption for chemicals used in cosmetics may not be as broad as it
seems. The EPA's authority under TSCA has the potential to play a
role in cosmetics regulation. Under TSCA, the EPA must coordinate
with other federal agencies in the research, development, collection,
dissemination, and utilization of data,178 and cooperate with other
federal agencies to utilize the resources of such agencies.179
Thus, if the EPA detennines that a chemical poses a risk of human
injury, it may ban or otherwise restrict it from all non-exempt uses
that pose such a risk. 80 The EPA's decision to ban or restrict the
non-exempt uses of a chemical would not automatically prompt the
FDA to issue a similar ban or restriction, but because TSCA requires
coordination and cooperation between the EPA and other federal
agencies, the FDA would likely take into account the EPA's safety
determination and more carefully scrutinize the chemical's cosmetic
use. This is both efficient and sensible, as, in all likelihood, the
"intimate bodily exposure" encountered through routine use of
cosmetics containing the chemical in question would be hazardous.
181
An EPA finding that a chemical poses an unreasonable risk of
human injury could pose other problems for cosmetics producers.' 82
Some dual-use chemicals are used primarily in TSCA-regulated
applications, with the cosmetics industry using only a small fraction
of the aggregate production volume of a given chemical. If the EPA
banned or otherwise limited these primary applications, it could
become uneconomical to manufacture the chemical if the cosmetics
industry requires only a relatively minute amount.'8 3  The EPA's
regulatory actions could thus eliminate the production sources of
177. Inventory Reporting Requirements, 42 Fed. Reg. 64572, 64586 (Dec. 23,
1977).
178. 15 U.S.C. § 2609 (2010).
179. Id. § 2625(a).
180. See generally id. § 2605 (authorizing the EPA to take regulatory measures
to protect against an unreasonable risk of human injury posed by chemical
substances, including the ability to ban manufacture and distribution in commerce,
restrict use, and impose labeling requirements).
181. Estrin, supra note 152, at 40; see supra Part II.A.2.
182. Estrin, supra note 152, at 40.
183. Id. at 40-41.
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some chemicals used in cosmetics.184 Finally an EPA finding that a
chemical presents an unreasonable risk of harm would likely deter
consumers from purchasing the product, and would trigger responses
from public interest groups.1
1. Regulatory Mechanisms under TSCA
The TSCA statutory and regulatory schemes may be helpful when
considering ways to improve cosmetics testing and regulation, but it
is important to note that, notwithstanding the exemption of cosmetics
from EPA review, the TSCA model is hardly perfect. Its
effectiveness with respect to obtaining chemical toxicity information
and policing existing chemicals has been limited at best. This
section sets out the TSCA regulatory mechanisms to discern lessons
for cosmetics reform.
The Senate's Commerce Committee report concerning the TSCA
legislation described it as a bill "designed to fill a number of
regulatory gaps," as it mandated the EPA to conduct premarket
review of chemical substances and mixtures, monitor industrial
chemicals for health and environmental impact, take a
comprehensive look at the hazards associated with chemicals, and
assign responsibility to obtain data about the health and
environmental effects of chemicals to manufacturers. 186
TSCA regulates two kinds of materials: "chemical substances" and
"mixtures."' 87 The statute and regulations define the term "chemical
substance" quite expansively' 88 to include "any organic or inorganic
substance of a particular molecular entity, including - (i) any
combination of such substances occurring in whole or in part as a
184. Id. at 41.
185. Id.
186. S. Rep. No. 94-698, at 1 (1976), reprinted in LIBR. OF CONG., LEGISLATIVE
HISTORY OF THE Toxic SUBSTANCES CONTROL ACT ""157 (1976). The Senate
TSCA bill was passed in lieu of the House bill. Id.
187. ELIZABETH BROWN ET AL., TSCA DESKBOOK: A PRACTITIONER'S GUIDE TO
THE Toxic SUBSTANCES CONTROL ACT 8 (1999). A mixture is a combination of
chemical substances. Id.
188. Id. ("This same expansive approach applies to many other key jurisdictional
terms in the statute, including 'chemical manufacturers' (defined to include
inporters of chemical substances) and 'chemical processors' (defined to include
many activities more traditionally understood as chemical use).").
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result of a chemical reaction or occurring in nature and (ii) any
element or uncombined radical."' 89
Despite TSCA's broad scope,190 the statute intentionally excludes
regulation of several categories of materials from the definition of
"chemical substance," including mixtures, pesticides, tobacco
products, nuclear materials, firearms and ammunition, and food,
drugs and cosmetic products. 191 These categories, with the exception
of mixtures, are all regulated under other federal statutes such as the
FDCA.192
TSCA defines mixtures as any combination of two or more
chemical substances not occurring in nature that also are not the
product of a chemical reaction. Although individual "chemical
substances" are subject to TSCA's pre-manufacture notice
requirements, which give the EPA 90 days to evaluate and consider
whether to restrict or ban the substances, the mixtures themselves are
not.194  This means that the EPA is not given the opportunity to
assess a new mixture before it enters production.
TSCA is a complex statute. Its key regulatory mechanisms include
the following:
Review of Existing Chemicals - Section 4 authorizes the EPA to
promulgate rules that require manufacturers/processors to test
189. 15 U.S.C. § 2602(2)(A) (2010). The EPA has interpreted the definition of a
"chemical substance" to reach quite broadly, even including some microorganisms.
See 40 C.F.R § 710.26(c) (2010). Section 3 of TSCA includes microorganisms and
their component chemicals, unless they are manufactured or distributed "for use as
pesticides, foods, food additives, drugs, cosmetics, and medical devices."
Statement of Policy; Microbial Products Subject to the Federal Insecticide,
Fungicide, and Rodenticide Act, and the Toxic Substances Control Act, 51 Fed.
Reg. 23,313, 23,324 (June 26, 1986). New microorganisms are subject to TSCA's
reporting requirements for new chemicals only if they are intergeneric. See 40
C.F.R. § 725.3. Intergeneric microorganisms are those that are "formed by the
deliberate combination of genetic material originally isolated from organisms of
different taxonomic genera." Id.
190. BROWN, supra note 187, at 8 (noting that Congress granted the EPA broad
authority, aiming to regulate chemicals that are manufactured, imported, processed,
used, or disposed of in the United States).
191. 15 U.S.C. § 2602(2)(b) (2010).
192. See BROWN, supra note 187, at 8 (citing 15 U.S.C. § 2602(2)(B)).
193. Id. at 9 (citing 15 U.S.C. § 2602(8)).
194. Id. (citing 15 U.S.C. § 2604).
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chemical substances and mixtures the EPA identifies to pose an
unreasonable risk to health or the environment.' 95
Review of New Chemicals - Section 5 regulates the manufacture
and import of new chemical substances in the United States.'96
Manufacturers of new chemicals must submit to the EPA a pre-
manufacture notice of their intent to produce a new chemical, along
with any data relating to the health or environmental effects of the
chemical, at least 90 days before importing or manufacturing the
chemical substance.197  Manufacturers of existing chemical
substances seeking to use or process them for a "significant new use"
are similarly required to provide 90 days notice. 198 The EPA may
restrict or ban production and distribution activities and/or the
"significant new uses" of these chemical substances if they pose an
unreasonable risk to the public health or the environment.' 99
Inventory of Chemical Substances - Section 8(b) requires the EPA
to establish and maintain an inventory of all chemicals manufactured
or processed in the U.S. from 1974.200 By 1980, EPA had compiled a
list of about 60,000 individual chemical substances,201 creating a
database of existing chemical substances. Any chemical substance
not on this list is considered a "new chemical substance" and must
undergo TSCA's review and approval procedures under Section 5.202
Direct Regulation of Existing Chemical Substances - Section 6
authorizes the EPA to prohibit or otherwise limit the manufacture,
processing, or distribution of existing chemical substances where
there is a "reasonable basis" to find that a chemical "presents or will
present an unreasonable risk of injury to health or the
environment." 203
195. 15 U.S.C. § 2603(a)(4) (2010).
196. Id. § 2604.
197. Id. § 2604(a)(1)(A).
198. Id. § 2604(a)(1)(B).
199. Id. §2604(f); see also 40 CFR 721.1 (2010).
200. Id. § 2607(b)(1); BROWN, supra note 187, at 7.
201. BROWN, supra note 187, at 7. Currently, the EPA's TSCA inventory
contains approximately 84,000 non-confidential identities of chemical substances.
The list is available at http://www.data.gov'raw/1630 (last visited Dec. 23, 2010).
202. BROWN, supra note 187, at 7.
203. 15 U.S.C. § 2605(a) (2010).
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Import/Export Requirements - Section 13 requires that any
chemical substance or mixture imported into the United States
comply with TSCA.204 The Secretary of Treasury and the EPA
Administrator are authorized to work together to promulgate
regulations regarding the importation of chemicals.205 Section 12(b)
requires individuals to notify EPA when they intend to export
chemicals for which the submission of data is required under Section
4 or Section 5.206
TSCA requires chemical producers to provide notice to the EPA of
their intent to manufacture or import a new chemical and any
available data pertaining to testing or associated health or
environental effects. 207 However, the EPA has revealed that most
pre-manufacture notices do not contain any testing data, and only 15
percent contain data related to environmental or health effects.208
Chemical manufacturers do not have an incentive to conduct safety
testing that can involve significant expenditures of time and
money. 209  Rather than providing data drawn from safety tests,
manufacturers simply provide estimates of the potential exposures to
new chemicals. Lacking sufficient data regarding a new chemical's
properties and effects, the EPA relies on a modeling approach known
as structure activity relationships analysis, whereby the new chemical
is compared to existing analogues based on their structural
* * 210
similarity.
204. Id §2612.
205. Id.
206. Id § 2611(b).
207. See supra, notes 196-99 and accompanying text (explaining that
manufacturers are required to submit a pre-manufacture notice and any available
health or environmental data 90 days before manufacturing a new chemical); see
also Rawlins, supra note 32, at 32.
208. Id (citing Testimony before the Committee on Environment and Public
Works, U.S. Senate, Chemical Regulation: Actions are needed to improve the
effectiveness of EPA's chemical review program, GAO-06-1032T, at 8, April 2,
2006 (statement of John B. Stephenson, Director, Natural Resources and
Environment)).
209. Testimony before the Committee on Environment and Public Works, U.S.
Senate, Chemical Regulation: Actions are needed to improve the effectiveness of
EPA's chemical review program, GAO-06-1032T, at 8, April 2, 2006 (statement of
John B. Stephenson, Director, Natural Resources and Environment).
210. Id. at 8.
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Chemical producers seeking to use existing chemicals have no
obligation to submit toxicity information unless the EPA first
promulgates a new test rule.211 Yet the EPA can do so only if it can
show by substantial evidence that the existing data on the chemical is
"'insufficient"' and that the agency has "'more than a theoretical
basis'" to suspect a risk associated with exposure to the chemical 2
This is a difficult burden to satisfy .213 It can require sizable
expenditures from the agency to meet this standard, and takes from
two to ten years for the EPA to finalize test rules for an existing
chemical. 214 The EPA has required testing of fewer than 200 of the
62,000 chemicals that exist in commerce since it began reviewing
them in 1979.215
2. An Illustration of TSCA's Inadequacies
On its face, the language of TSCA appears to grant the EPA wide
authority over chemical production. However, the agency's ability to
promulgate restrictions over chemicals has been hampered by the
lack of safety data available for its assessments. 216 This data gap
compounds the EPA's difficulties meeting courts' high evidentiary
burden to justify restrictions on chemical manufacturers.
Manufacturers submitting to the EPA a pre-manufacture notice of
intent to use a "new chemical" or a "significant new use" notice must
include all testing data in their possession regarding health or
environental effects, and any other relevant data of which they have
217knowledge. A manufacturer must develop and include additional
mandatory test data in only two situations. First, when submitting a
pre-manufacture notice regarding a "new chemical substance," the
manufacturer must include data relating to environmental and health
risks outlined in TSCA Section 4.218 Second, chemical
211. Id. at 4; see also supra, note 203 and accompanying text (stating that
manufacturers of an existing chemical must submit data only if the EPA finds that
the chemical poses an unreasonable risk to health or the environment).
212. Id. at 5.
213. Id. at 5-6.
214. Id. at 6.
215. Id.
216. See supra notes 207-10 and accompanying text.
217. 15 U.S.C. § 2603(a) (2010); BROWN, supra note 187, at 7.
218. BROWN, supra note 187, at 7.
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manufacturers need to submit additional test data when the substance
they seek to use is included on the list of the substances that the EPA
has determined may present an unreasonable risk of injury to the
public health or the environment.219 If a pre-manufacture notice
contains insufficient information for the EPA to determine health or
environmental effects of a new substance, the EPA can restrict or
prohibit its manufacture. 220  Other than these circumstances, the
scope of testing of a new substance or a significant new use of an
existing substance is left up to the manufacturer, who is not required
to submit even minimum data set setting forth basic chemical identity
or toxicology. 221
After reviewing the manufacturer's test data, the EPA may prohibit
or restrict the use or production of chemicals it finds by "substantial
evidence" to pose an "unreasonable risk" of human injury or
enviromnental hann.222  This balancing test pennits the EPA to
restrict or prohibit the use of a chemical only if the severity and
likelihood of the potential injury from its use offsets the economic
harm that the restriction would impose on manufacturers and
consumers.223 Under TSCA, any such restrictions must be the least
burdensome that will also adequately protect against the risk to
human health or the enviromnent.224 Detennining just what exactly
constitutes "harm" or "adequate safety" can be difficult, and is
perhaps unjusticiable.
219. Id.; see supra notes 195-206 and accompanying text (summarizing the key
regulatory mechanisms of TSCA); see also 15 U.S.C. § 2603(a) (2010).
220. 15 U.S.C. § 2603(a) (2010).
221. Id. A minimum data set for existing chemicals includes chemical identity,
biological fate and transport data, volumes, toxicological other information. Safe
Cosmetics Act of 2010, H.R. 5786, 111 Congress (2010).
222. 26 U.S.C. § 2604(f) (2010); see supra note 203 and accompanying text; see
also Rawlins, supra note 32, at 32-33.
223. Rawlins, supra note 32, at 33-34.
224. 15 U.S.C. § 2605(a) (2010); see also Whitman v. Am. Trucking Ass'ns,
Inc., 531 U.S. 457, 472-76 (2001) (discussing the difficulties of determining what
constitutes "adequate" protection of human health and the environment); Rawlins,
supra note 32, at 34.
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The EPA's unsuccessful attempt to ban asbestos, a well-known
carcinogen,225 illustrates the difficulty of conducting TSCA's
balancing test. In 1991, in Corrosion Proof Fittings v.
Environmental Protection Agency,226 the Fifth Circuit struck down an
EPA regulation prohibiting almost all manufacturing and use of
asbestos. 227 Manufacturing industry advocates brought suit against
the EPA, arguing that the regulation was not based on "substantial
evidence." 22 8 The court ruled in fav or of the petitioners, finding that
the EPA had considered insufficient data and had performed flawed
calculations when promulgating the regulation.229
The court held that the costs and benefits of the regulation had to
be discounted over time to avoid an arbitrary calculation.230 Because
the agency analyzed the cost of the regulation using the time a person
was exposed to asbestos, not the time of his or her injury, the court
found the EPA had not measured costs and benefits properly.231 In
225. See Rawlins, supra note 32, at 34; see also Asbestos, AM. CANCER SOC'Y,
http:x/www. cancer.org/Cancer/CancerCauses/OtherCarcinogens/IntheWorkplace/as
bestos (last revised Nov. 8, 2010).
226. Corrosion Proof Fittings v. Enytl. Prot. Agency, 947 F.2d 1201 (5th Cir.
1991).
227. Rawlins, supra note 32, at 34 (citing Andrew Hanan, Note & Comment,
Pushing the Environmental Regulatory Focus a Step Back: Controlling the
Introduction ofNew Chemicals Under the Toxic Substances Control Act, 18 AM. J.
L. & MED. 395, 415 (1992) (providing a detailed analysis of Corrosion Proqf
Fittings decision)).
228. Corrosion ProofFittings, 947 F.2d at 1207.
229. Id at 1227.
230. Id. at 1218. The Court of Appeals reasoned that "[w]hen the EPA does
discount costs or benefits, however, it cannot choose an unreasonable time upon
which to base its discount calculation. Instead of using the time of injury as the
appropriate time from which to discount, as one might expect, the EPA instead
used the time of exposure." Id.
231. Id. at 1218-19. The court explained,
We do not today determine what an appropriate period for the EPA's
calculations would be, as this is a matter better left for agency
discretion.... We do note, however, that the choice of a thirteen-
year period is so short as to make the unquantified period so
unreasonably large that any EPA reliance upon it must be displaced.
Id. at 1219. The court stated that when the EPA does discount costs or benefits, it
cannot choose an unreasonable time upon which to base its discount calculation.
Instead of using the time of injury as the appropriate time from which to discount,
as one might expect, the EPA instead used the time of exposure. Id. at 1218-1219.
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addition the court found that the EPA improperly concluded that the
number of lives saved by the regulation were unquantifiable.232 The
Court of Appeals found the EPA's approach improper233 and relied
on both of these miscalculations to strike down the regulation.
The court went on to criticize the EPA for failing to consider less
restrictive alternatives to the regulation it had proposed. 234 WAhile the
EPA did determine that the use of fibers in lieu of asbestos was less
harmful, the court found this to be inadequate justification for a
wholesale asbestos ban. 235 The court noted that it would be many
years before experimental toxicological data would be available to
forecast the health effects of substitutes. 23 6  Therefore, the
confirmation of any hazards would take even longer and the risks
associated with the substitutes were likely to change as the industry
created new substitutes. 237 Although the EPA did not have a duty to
explore all of the possible less restrictive alternatives, the court held
that the agency must fully evaluate the significant risks posed by the
substitutes before it could impose a ban on asbestos. 23 8
The EPA's inability to implement an asbestos ban illustrates the
5th Circuit's high, and perhaps impractical, evidentiary burden.2 39 A
reasonable scientific expert may have concluded "substantial
evidence" existed to show that asbestos posed an "unreasonable
According to the American Cancer Society, illness from asbestos can take
anywhere from 10-20 years after the exposure. See Asbestos, supra note 225.,
232. See Corrosion ProofFittings, 947 F.2d at 1218-19.
233. Id. at 1219 ("'While TSCA contemplates a useful place for unquantified
benefits beyond the EPA's calculation, unquantified benefits never were intended
as a trump card allowing the EPA to justify any cost calculus, no matter how
high.").
234. Id. at 1229. The court faulted the EPA for failing to consider the less
restrictive alternative of requiring improvements in workplace conditions before
banning the use of asbestos. It noted that when a product is potentially dangerous
the proper course of action is to consider each regulatory option concerning the
product, beginning with the least burdensome, and the costs and benefits of
regulation under each option. Id. at 1217. ("The EPA cannot simply skip several
rungs, as it did in this case, for in doing so, it may skip a less-burdensome
alternative mandated by TSCA.").
235. Id. at 1221.
236. See id. at 1224.
237. Id. at 1224-25.
238. Id. at 1225.
239. Id.
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risk," yet, the court nevertheless struck the regulation because the
EPA had not calculated the level of risk with sufficient precision.240
It may be impracticable to employ such precision.241 Indeed, the
EPA has stated that the legal burden to demonstrate an "unreasonable
risk" is so high that it has been discouraged from issuing regulations
242
under TSCA. The EPA has issued regulations to prohibit or
restrict the production or use of only five existing chemicals or
chemical groups since the statute was enacted in 1976.243 Thus, even
if TSCA covered cosmetics, implementing robust regulations is so
difficult that it would be highly unlikely that any of their contents
would be banned or significantly restricted.
Given the weaknesses of TSCA and the FDCA, it is not surprising
that advocates have sought to amend these statutes. The next section
explores these efforts and their potential impacts on improving the
cosmetics regulation.
III. PROPOSED REFORM OF THE FDCA AND TSCA
Though the regulatory framework for cosmetics has remained
largely unchanged for decades, a reform movement is gathering
steam.244 This section will examine recent proposals for reforming
the FDCA and the TSCA, highlighting the significant differences
between the proposed legislation and the currently controlling
statutes. As an introduction, this section will discuss two recent
240. Rawlins, supra note 32, at 35. (citing Andrew Hanan, Note & Comment,
Pushing the Environmental Regulatory Focus a Step Back: Controlling the
Introduction ofNew Chemicals Under the Toxic Substances Control Act, 18 AM. J.
L. & MED. 395, 414 (1992)).
241. Id.
242. Id (citing Testimony before the Comm. on Env't and Pub. Works, U.S.
Senate, Chemical Regulation: Actions are needed to improve the effectiveness of
EPA's chemical review program, GAO-06-1032T, and summary of findings (April
2, 2006 statement of John B. Stephenson, Director, Natural Resources and
Environment, EPA)).
243. Id. The five chemicals restricted are PCBs, chlorofluorocarbons, dioxin,
hexavalent chronmium and asbestos only in products not historically containing
asbestos as of 1999. LOWELL CENTER FOR SUSTAINABLE PRODUCTION, THE
PROMISE AND LIMITS OF THE UNITED STATES ToXic SUBSTANCES CONTROL ACT 3
(October 10, 2003).
244. See supra Part I.A. (discussing recent developments in the movement for
reform of cosmetics regulation).
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reforn measures in Europe, the New Cosmetic Product Regulation
and the Registration, Evaluation and Authorization of Chemicals
Regulation (REACH), which can serve as models for reform in the
United States.
A. A ModelJbr Reform: Regulation in Europe
The European Union (EU) provides a model for cosmetic
regulation reform. The EU has promulgated laws that follow the
environental justice movement's precautionary principle,245 placing
the burden on chemical companies to prove the safety of their
products, and in the interim, banning ingredients that may be
harmful.246
In 1976, the EU passed its first major piece of cosmetics legislation
with the Cosmetics Directive, which identified an extensive list of
banned chemicals and instituted specific testing and data
requirements for cosmetic ingredients.247 As a directive, as opposed
to a regulation, the Cosmetics Directive was non-self-executing,
allowing member states flexibility in applying its provisions. 248 The
goal of the Directive was to require manufacturers to create a full
technical file that included infornation on a product's formulation,
the manufacturing process, proof of safety, claims included on
product packaging, and a record of consumer health-related claims.249
Despite its progressive and ambitious approach to cosmetics
oversight, the Cosmetics Directive's nature as a non-self-executing
directive, as opposed to a binding regulation, limited its
effectiveness. 250
245. Deborah Katz, The Misnatch Between the Biosafety Protocol and the
Precautionary Principle, 13 GEO. INT'L ENVTL. L. REv. 949, 950-51 (2001)
(defming the precautionary principle).
246. Cosmetics Directive, Council Directive 76/768/EEC, 1976 O.J. (L 262) 12...
247. Id.
248. Review qf Cosnetics Directive, EUROPEAN COMMISSION CONSUMER
AFFAIRS, (2010), http://ec.europa.eu/consumers/sectors/cosmetics/documents!
revision/index en.htm (last update Nov. 8, 2011).
249. Roseann B. Termini & Leah Tressler, American Beauty: An Analytical IView
of the Past and Current Effectiveness qf Cosmetic Safety Regulations and Future
Direction, 63 FOOD & DRUG L.J. 257, 269 (2008).
250. EUROPEAN COMMISSION CONSUMER AFFAIRS, REVIEW OF COSMETICS
DIRECTIVE (2010), available at http:/ /ec.europa.eu/consumers/sectors/cosmetics!
documents/revision/index en.htim.
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To ensure uniformity in the application of provisions, the EU
recast the Cosmetics Directive as the New Cosmetic Product
Regulation in 2009.251 The New Cosmetic Product Regulation is
self-executing and does not allow for diverging application by
member states.252 The Regulation only allows variety in regard to
penalties; member states are tasked with prescribing their own
"effective, proportionate and dissuasive" penalties for violating the
Regulation.25 3 The Regulation will not take effect until the repeal of
the Cosmetic Directive occurs on July 11, 2013.254 The Cosmetic
- - -255Directive still applies in the inteim.
The EU has additional authority to regulate the safety of cosmetics
under the Registration, Evaluation and Authorization of Chemicals
Regulation (REACH).25 6 REACH is similar to the TSCA, in that
though it does not specifically apply to cosmetics, it does apply to
chemicals that may be used in cosmetics. REACH requires chemical
manufacturers to publically register substances with the European
Chemicals Agency (ECHA) to increase transparency and improve
protection of human health and the environnent.257 If a substance
contains properties of "very high concern," an applicant must
demonstrate that there is not a safer alternative and that the risks
associated with its use are "adequately controlled" or that "the socio-
economic benefits of their use outweigh the risks." 258 The ECHA
may withdraw authorization of the original substance if a safe
251. EUROPEAN COMMISSION CONSUMER AFFAIRS, supra note 236.
252. Regulation 1223/2009 of the 1223/2009, 2009, O.J. (L.352) 59.European
Parliament and of the Council of 30 Novemberl223/2009, 2009 on Cosmetic
Products,, O.J. (L.352) 59. O.J. (L. 342) 2.
253. Id. at 37.
254. Id. at 38, 40.
255. Id. at 38.
256. Registration 1907/2006 of the European Parliament and of the Council of 18
Dec. 2006 concerning the Registration, Evaluation, Authorisation and Restriction
of Chemicals (REACH), 2007 O.J. (L) 13.
257. EUROPEAN COMMISSION ENVIRONMENT DIRECTORATE GENERAL, REACH
IN BRIEF 4 (Oct. 2007), http://ec.europa.eu/environment/chemicals/reach/pdf7
2007_02_reach in brief.pdf.
258. EUROPEAN COMMISSION ENVIRONMENT DIRECTORATE GENERAL, supra
note 257, at 5.
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substitute becomes available.259 As a regulation, Member States of
the EU are required to enforce REACH provisions and penalties. 260
B. The Proposed Safe Cosmetics Act of 2010
The strong cosmetics reform movement in Europe has not gone
unnoticed around the in the United States. This section will examine
a bill that attempted to secure sweeping reform of the FDCA and
modernization of cosmetics regulation in the United States: the Safe
Cosmetics Act of 2010.
On July 21 2010, Representative Jan Schakowsky of Illinois and
22 co-sponsors, all members of the Democratic Party, introduced the
Safe Cosmetics Act of 2010 in the House of Representatives. 261 The
bill was immediately referred to the House Committee on Energy and
Commerce and the Committee on Education and Labor, where it
languished until the end of 11 1th Congress on January 3, 2011.262
Representative Schakowsky re-introduced the Safe Cosmetics Act in
June 2011, but as of October 2011, it had not moved out of
committee.263
The bill sought to amend the Food Drug and Cosmetic Act
(FDCA) to require:
(1) annual registration of any establishment engaged in
manufacturing, packaging, or distributing cosmetics for use
in the United States;
(2) new fees imposed on manufacturers to provide for
oversight and enforcement of cosmetics regulations:
(3) ingredient labeling and disclosure of information on
ingredients; and
259. EUROPEAN COMMISSION ENVIRONMENT DIRECTORATE GENERAL, supra
note 257, at 5.
260. RJK4CI Enforcement, EUROPEAN COMMISSION (May 20, 2010),
http://ec.europa.eu/environment/chemicals/reach/enforcement en.htm.
261. While cosmetics regulation is not a traditionally partisan issue, it has not
received notable support from the Republican Party. No Republican has sponsored
or co-sponsored any of the bills calling for increased cosmetic regulation in 111
Congress. Safe Cosmetics Act of 2010, H.R. 5786, 111 Congress (2010); see
supra note 260; see infra note 271.
262. Id.
263. Safe Cosmetics Act of 2011, H.R. 2359, 111th Congress (2011).
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(4) adverse event reporting.264
The bill also would have imposed new requirements on the FDA
and the Department of Labor. For example, under the proposed
statute, the Secretary of the FDA would be required to:
(1) establish a list of prohibited or restricted ingredients
and a list of ingredients that are safe without limits for use
in cosmetics;
(2) develop a priority assessment list of ingredients that
cannot be included on either of the other two lists because
of a lack of authoritative information on the safety of the
ingredient(s); and
(3) establish minimum data requirements and test protocols
to be used by manufacturers to assess the safety of
cosmetic ingredients. 265
Additionally, the bill was drafted to permit the FDA to issue
recalls, regulate nanotechnology, 266 and encourage alternatives to
animal testing.267 The FDA would be able to request that a
distributor of a misbranded or adulterated cosmetic voluntarily recall
the product and provide notice to those affected.268 The FDA could
also order a mandatory recall after an informal hearing or even issue
emergency recall orders if the Cormnissioner perceived an "imminent
threat of serious adverse health consequences or death to humans."269
To promote collaboration among federal agencies, the bill called
for the establishment of the Interagency Council on Cosmetic Safety,
264. Id.
265. Id.
266. Nanotechnology involves the manipulation of nanoscale materials - those
measured in nanometers, one-billionth of a meter. Nanoscale materials are of
concern to the FDA as they may have altered magnetic, electrical, chemical or
biological activity. In turn, these differences may create safety issues different
from larger or smaller counterpart materials. FDA NANOTECHNOLOGY TASK
FORCE, NANOTECHNOLOGY (July 25, 2007), http://xwww.fda.govidownloads!
ScienceResearch!SpecialTopics/Nanotechnology/ucmI 10856.pdf.
267. H.R. 5786, § 616.
268. Id. § 616(b).
269. Id. § 616(d)-(e).
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which would be composed of representatives from several federal
agencies, including the National Institute on Environmental Health
Sciences, the Centers for Disease Control and Prevention, the OSHA
and the EPA.27 0
The introduction of the Safe Cosmetics Act of 2010 was met with
opposition from both large and small cosmetics manufacturers. The
Indie Beauty Network, a trade organization representing over 500
small, independent cosmetics and soaps companies, strongly opposed
the bill, contending that the bill's registration, disclosure and safety
testing requirements would be onerous to small businesses. 271 They
argued that amending the bill to include a small business exception
that would relax fees and requirements would benefit the nation's
economy and prevent small cosmetics manufacturers from going out
of business.2 72
The Personal Care Products Council (PCPC), the leading trade
organization representing the cosmetics industry, also opposed the
bill. The PCPC argued the Safe Cosmetics Act was based on non-
credible science and created mandates the FDA would be unable to
achieve.273 Instead, the PCPC proposed its own measures to address
cosmetics oversight and supported passage of another bill seeking to
reform the FDA, the FDA Globalization Act of 2009.274 This Act
would not have permitted the FDA to issue recalls of violative
270. Id. The proposed legislation also sought to improve safety and health in
cosmetics-related workplaces. The Secretary of Labor would have been required to
promulgate an occupational safety and health standard for use in cosmetics
distribution workplaces and salons. See id. at .
271. About IBV, INDEPENDENT BEAUTY NETWORK,,
http://indiebeautynetwork.com/channel-ibnyou (last updated May 23, 2009); Donna
Maria, Indie Beauty Network Opposes H.R. 5786 Safe Cosnetics Act of 2010,
INDEPENDENT BEAUTY NETWORK (July 29, 2010),
http:// x xwww.indiebusinessblog.com/indie-beauty-network-opposes-h-r-5786-safe-
cosmetics-act-of-20 10/.
272. See Indie Beauty Network Opposes H.R. 5786 Safe Cosmetics Act of 2010,
supra note 271.
273. Statement by Lezlee Westine President and CEO of the Personal Care
Products Council in Response to the Safe Cosmetics Act of 2010 Introduced Today
in Congress by Representatives Jan Schakowsky (D-IL), Edward Markey (D-MA)
and Tammy Baldwin (D-WI) (July 21, 2010) (on file with author).
274. Id.; see also Food and Drug Administration Globalization Act of 2009, H.R.
759, 111th Cong. (2009).
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cosmetics. 27 The FDA Globalization Act, like the Safe Cosmetics
Act of 2010. remained stalled in committee until the end of the 111tI
Congress. 276
C. The Toxic Chemicals Safety Act and the Safe Chemicals Act of
2011
The Safe Cosmetics Act of 2010 is similar to two additional bills
introduced in Congress at the same time. Democratic Representative
Jan Schakowsky's Toxic Chemicals Safety Act (TCSA) 277 and New
Jersey Democratic Senator Frank Lautenberg's Safe Chemicals Act
of 2011278 each sought to amend TSCA. The TCSA's and SCA's
safety standards are somewhat different, but both seek to implement
health-based standards for the EPA to use when assessing chemicals'
safety.279
TCSA would have required that, accounting for its aggregate and
cumulative exposure, a chemical "not [be] reasonably anticipated to
present a risk of injury to health or the environment."2 80 In addition,
the EPA would have been charged with protecting "the public
exposure from adverse effects, including effects on the
environment." 28 1 The Safe Chemicals Act would require the EPA to
use the best available science to review any existing safety data
regarding the impact of cumulative exposure to a chemical.2 8 2 Under
275. H.R. 759, 11Ith Cong.
276. Id. As of April 2011, the bill has not been re-introduced. THOAAS,
LIBRARY OF CONGRESS, http: /thomas.loc.gov/ (last visited May 9, 2011).
277. The Toxic Chemicals Safety Act, H.R. 5820, 110th Cong. (July 22, 2010),
available at http://frwxebgate.access.gpo.govicgi-bin/
getdoc.cgi?dbname= 111 cong bills&docid=f:h5820ih.txt.pdf (last visited Feb. 16,
2012). This bill was introduced on July 22, 2010 by representatives Rush,
Waxman, Castor, Degette, Schakowsky, and Sarbanes. It died at the end of the
2010 congressional session on Dec. 31, 2010. Id.
278. See The Safe Chemicals Act of 2011, S. 847, 112th Cong. (April 14, 2011).
Senator Lautenberg had introduced similar legislation in 2010. See The Safe
Chemicals Act of 2010, S. 3209, 110th Cong. (April 15, 2010).
279. Linda-Jo Schierow, Cong. Research Serv., R41335, Proposed Amendments
to the Toxic Substances Control Act Senate and House Bills Compared with
Current Law (2010), available athttp://''www.fas.org/sgp/crs/misc R41335.pdf.
280. Id. (citing H.R. 5820).
28 1. Id.
282. S. 847, 111th Cong.
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the Safe Chemicals Act, "a chemical substance meets the safety
standard only if the Administrator finds that there is a reasonable
certainty that no hann will result to human health or the environment
from aggregate exposure to the chemical substance." 283
While both TCSA and the Safe Chemicals Act would require that
the EPA compile minimum data sets for all existing chemicals within
five years of enactment, a key difference between the bills is that
they structure their priority lists for expedited safety standard
determinations differently. 284 TCSA would have required the EPA to
create a single priority list containing no fewer than 300 chemical
28
substances. 2 Rather than using a single list, the Safe Chemicals Act
would create a three-tiered system of "priority classes," into which
all chemicals would be grouped.2 86 Within one year of enactment,
the Safe Chemicals Act would require the EPA administrator to
assign from 20 to 30 chemicals into "priority class 1" which would
contain those chemicals that require immediate risk management.287
The Administrator would assign chemicals with "more-than-a-
theoretical concern" regarding whether they satisfy the Safe
Chemicals Act safety standard into priority class 2.288 Priority class 3
would contain those "chemical substances that the Administrator
determines require no irmnediate action."289
Both bills would have amended TSCA significantly, attempting to
shore up areas where the current statute has been minimally effective.
The Enviromnental Defense Fund provides an excellent chart,
283. Id.
284. Id; The Toxic Chemicals Safety Act, H.R. 5820, 110th Cong. (July 22,
2010). See also infra, note 221, for a definition of the term "minimum data set."
285. H.R. 5820, 110th Cong..
286. The Safe Chemicals Act of 2011, S. 847, 112th Cong. (April 14, 2011).
287. Id.
288. Id.
289. Additionally, TCSA specified 19 chemicals as "chemicals of highest
concern," while the Safe Chemicals Act would leave the identification of such
chemicals to the EPA's discretion. H.R. 5820, Safe Chemicals Act of 2011, S. Res.
847, 112th Cong. (2011); Toxic Chemicals Safety Act, H.R. Res. 5820, 110th
Cong. (2010).
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adapted here, comparing the current TSCA with the proposed
amendments under TCSA and the Safe Chemicals Act of 2011:290
Safety Data
Under proposed
TCSA/Safe Chem. Act
Up-front data call-ins for
all chemicals would be
required. Manufacturers
must develop and make
public a Minimum Data
Set (MDS) on all new and
existing chemicals
sufficient to determine
safety.
290. Richard Denison, TSCA Vs. Toxic Chemicals Safety Act qf 2010 (Sept. 8,
2010), http://notaguineapig.org /page.cfn?taglD=5 8972 (text amended for the
purposes of this report).
Currently under
TSCA
In a data call-in, EPA
requires a
manufacturer to
submit information
about a chemical,
including the amount
of a chemical it is
processing and all
environmental safety
and health studies
concerning the
chemical. EPA rarely
exercises its authority
to issue a data call-in
on existing chemicals;
even more rarely
requires such
chemicals to be
tested; and EPA does
not require
manufacturers to
submit a Minimum
Data Set (MDS), used
to assess safety, for
new chemicals.
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Currently under Under proposed
TSCA TCSA/Safe Chem. Act
Burden of EPA is required to Industry would bear the
Proof prove harm before it legal burden of proving
can regulate a chemicals are safe before
chemical. being marketed.
Assessment of
Safety
No mandate exists to
assess the safety of
existing chemicals.
New chemicals
undergo a severely
time-limited and
highly data-
constrained review
typically insufficient
to assess safety.
Both new and existing
chemicals would be
subject to safety
determinations as a
condition of entering or
remaining on the market,
using "the best available
science," which would be
detennined in
consultation with the
National Academy of
Sciences.
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Currently under
TSCA
When the EPA
undertakes a chemical
assessment there is no
requirement to assess
the risks from all
sources of exposure to
a chemical, or to
assess the risks to
vulnerable
populations. The
statute provides no on
how to determine
whether a chemical
presents an
"unreasonable risk."
EPA has not been able
to regulate even
chemical substances
of the highest
concern, such as
asbestos, under
TSCA's
"unreasonable risk"
cost-benefit standard.
Assessments often
drag on indefinitely
without conclusion or
decision.
Scope of
Assessment
Under proposed
TCSA/Safe Chem. Act
The safety standard would
require EPA to account
for aggregate and
cumulative exposures to
all uses and sources of a
chemical, and to ensure
protection of vulnerable
populations that may be
especially susceptible to
chemical effects (e.g.,
children, a developing
fetus) or subject to
disproportionately high
exposure (e.g.,
communities living near
contaminated sites or
chemical production
facilities).
Chemicals would be
assessed under a health-
based standard, requiring
manufacturers to prove
they are safe. Deadlines
for decisions would be
specified and EPA would
have authority to restrict
production and use, or
place conditions on, any
stage of the lifecycle of a
chemical needed to ensure
safety.
Regulatory
Action
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Currently under Under proposed
TSCA TCSA/Safe Chem. Act
Chemicals
and
Exposures of
High
Concern
Information
Access
The statute provides
no criteria to clarify
how EPA should
identify and prioritize
chemicals or
exposures of greatest
concern, leaving such
decisions to case-by-
case judgments by the
agency.
Companies are free to
claim, often without
providing any
justification, that most
information they
submit to EPA is
confidential business
information (CBI),
denying access to the
public, state, and local
governments. EPA is
not required to review
such claims, and the
claims never expire.
EPA would be required to
develop and apply criteria
to identify toxic
chemicals that persist and
build up in the
enviromnent and people,
and then promptly
mandate controls to
reduce use of and
exposure to such
chemicals. The EPA
would specifically
identify and address "hot
spots," where people are
subject to
disproportionately high
exposure.
All confidential business
information (CBI) claims
would ha-ve to be justified
up front. EPA would be
required to review such
claims and only approved
claims would stand.
Approved claims would
expire after a period of
time. Other federal
government agencies, as
well as state and local
governments, would have
access to CBI for
regulatory purposes.
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Rulemaking
Requirements
Currently under
TSCA
To require testing of a
chemical of concern
or take other actions,
EPA must promulgate
regulations that can
take many years and
resources to develop.
This long process is
the result of the overly
high burden of
proving that a
chemical poses an
"unreasonable risk"
and that there is no
superior alternative
chemical that does not
pose such a risk. Yet,
EPA must show
potential for a
chemical to cause
harm in order to
require testing to
establish that it poses
an unreasonable risk,
a "catch-22."
Under proposed
TCSA/Safe Chem. Act
In addition to the
Minimum Data Set
requirement, EPA would
have authority to issue an
order (rather than develop
a regulation) to require
reporting of existing data
or additional testing, and
need not first show
evidence of harm.
Among the most important proposed changes in TCSA and the
Safe Chemicals Act is shifting the burden to the chemical industry to
prove that chemicals are safe. 291 No longer would the EPA have the
burden to show that a chemical posed an unreasonable risk of injury
to health or environment before it could regulate its use.292
291. See Toxic Chemicals Safety Act, H.R. Res. 5820, 110th Cong. (2010), Safe
Chemicals Act of 2010, S. Res. 3209, 111th Cong. (2010).
292. See id.
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D. Comparing the Toxic Chemicals Safety Act and the Safe
Cosmetics Act of 2010.
The Toxic Chemicals Safety Act (TCSA), the Safe Chemicals Act
of 2011, and the Safe Cosmetics Act of 2010 (SCA) would make
parallel changes to the ways in which the EPA and the FDA,
respectively, review and regulate chemicals. 293 These bills would
encourage a similar scope of reform: each bill embraces the
precautionary principle,294 shifting the burden to manufacturers to
prove that a chemical is safe. The bills can be viewed collectively as
a response to the dramatic increase of scientific data linking negative
health consequences to chemical exposure.295 Notable similarities
include:
TCSA and the Safe Cosmetics Act sought to make similar changes
to the safety standard used by the respective agencies. TCSA would
have changed the TSCA requirement that the EPA show that an
existing chemical poses an "unreasonable risk of injury" before
issuing restrictions on a chemical to a standard where the agency
would take into account the aggregate exposure of a chemical for all
intended uses in establishing that there is a "reasonable certainty that
no harm" will result to public health.296  Similarly, the safety
standard under the Safe Cosmetics Act of 2010 would have required
the FDA to determine "that there is a reasonable certainty that no
harm will result from aggregate exposure to the ingredient or
cosmetic" before approving a product for sale.297
293. See Mark N. Duvall & Graham C. St. Michel, Press Release, Cosmetics
Safety Bill Would Incorporate TSCA Bill Provisions, BEVERIDGE AND DIAMOND,
P.C. (Aug. 2, 2010), http://www.bdlaw.com news-935.htnil (last visited Nov. 20,
2010).
294. See Katz, supra note 245, at 950-51 (defining the precautionary principle).
295. See Frank R. Lautenberg, Safe Chemicals Act of 2011,
http://1autenberg.senate.goviassets/SafeChem-Summary.pdf (last visited Nov. 10,
2011) (describing how TSCA has not been amended since its adoption "despite
huge changes in chemical production and use and our state of knowledge about
how chemicals can harm health and the environment").
296. See Toxic Chemicals Safety Act of 2010 H.R. Res. 5820, 110th Cong.
(2010).
297. Safe Cosmetics Act of 2010, H.R. Res. 5786, 111th Cong. (2010).
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Both bills would create a public database of health and safety
studies on the internet.298
Under both bills, the FDA and EPA would have to establish a
priority list of chemicals that have precedence for safety
assessments. 299 TCSA identifies 14 specific chemicals for inclusion
on this list, including BPA and seven phthalates. 0 0 In addition, both
bills would require that the priority list contain at least 300 chemicals
at any given time.301
Under both bills, a manufacturer would have had the burden to
prove that a chemical or cosmetic product meets the "reasonable
certainty of no harn" safety standard.302 This represents a marked
change from current law, which requires the FDA or EPA to prove
that a product or chemical is harmful. To meet this burden, both bills
require that manufacturers submit a Minimum Data Set (MDS).30
HWhile the Safe Cosmetics Act would leave the establishment of these
criteria up to the FDA, TCSA II would require the EPA to establish
an MDS that includes information on "(i) chemical identity; (ii)
substance characteristics; (iii) biological and environmental fate and
transport: (iv) toxicological properties: (v) volume manufactured,
processed, or imported; (vi) intended uses; and (vii) exposures from
all stages of the chemical substance or mixture's lifecycle that are
known or reasonably foreseeable to the party submitting the data
set."304
Differences among the bills would include:
Unlike TCSA, the Safe Cosmetics Act of 2010 actually establishes
a baseline definition of a "reasonable certainty of no harm" as either
a one-in-a-million risk of harm or no risk of harm.305
The Safe Cosmetics Act of 2010 would eliminate trade secret
protection for cosmetics ingredients. 306 Although TCSA would still
298. Toxic Chemicals Safety Act, H.R. 5820, 111th Cong. (2010); Safe
Chemicals Act of 2010; S. Res. 3209 111th Cong. (2010).
299. Id.
300. H.R. 5820, 11Ith Cong.
301. Id.; S. 3209, 111th Cong.
302. Id.
303. Id.
304. Id.
305. Id.
306. Safe Chemicals Act of 2010; S. Res. 3209 11Ith Cong. (2010).
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allow manufacturers to designate information as confidential,307 they
would be required to submit a justification for each claim of
confidentiality and a certification that the information is not
otherwise available to the public.308  Importantly, a confidential
designation would not preclude the EPA from evaluating chemicals
claimed as trade secrets for safety. 309
Unlike TCSA, the Safe Cosmetics Act of 2010 would require
CEOs to certify, after making a good faith inquiry, that a chemical
meets the safety standard (that there is "a reasonable certainty of no
harm") or that there is insufficient data to determine whether a
cosmetic or its ingredients meet the safety standard. 0
Both TCSA and the Safe Cosmetics Act of 2010 sought to
implement a more robust system than the current legislative scheme
to assess chemicals for safety by phasing out the most hazardous
substances and increasing the transparency and availability of
information about chemicals.31 Representative Jan Schakowsky has
reintroduced the Safe Cosmetics Act. 312 I ie Snate has ii tn
any action on the Safe Chemicals Act of 2011.
IV. COSMETICS REGULATION AT THE STATE LEVEL
Cosmetics regulation reform at the federal level would create
comprehensive change, protecting consumers throughout the country.
The 1 11t" Congress's inability to pass cosmetics regulation reform
forward will likely inhibit efforts to overhaul the FDCA and
TSCA 3" there is great opportunity to pursue improved regulation of
307. Toxic Chemicals Safety Act, H.R. 5820, 111th Cong. (2010).
308. Id.
309. See id; Safe Cosmetics Act of 2010, H.R. Res. 5786, 111th Cong. (2010),
Toxic Chemicals Safety Act, H.R. Res. 5820 111th Cong. (2010).
3 10. Id.
311. The Safe Cosmnetics Act qf 2010: What it Means for Cosmetics Companies,
THE CAMPAIGN FOR SAFE COSMETICS, http:/'xwww.safecosmetics.org/
article.php?id=695#tsca (last visited Dec. 27, 2010).
312. Safe Cosmetics Act of 2011, H.R. Res. 2359, 112th Cong. (2011),
http://".,,'www.gpo.gov/'fdsys/pkg/BILLS-i 12hr2359ih/pdf/BILLS-112hr2359ih.pdf.
313. Safe Chemicals Act of 2011, S. Res. 847, 112th Cong. (2011); see supra
note 278.
314. See infra Part V (discussing current political challenges to cosmetics
regulation reform).
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cosmetics at the state and local levels. This section will focus on the
New York State and New York City legislative and executive bodies
and their ability to achieve cosmetics reform. As an introduction, the
Report will discuss cosmetics reform in other states.
A. The California Safe Cosmetics Act and Efforts in Other States
Just as the European Union provides an excellent model for reform
on the federal level, California's ability to institute a more stringent
system for review of cosmetics at the state level could be highly
instructive for reformers at the state level. Governor Arnold
Schwarzenegger signed the California Safe Cosmetics Act into law
on October 8, 2005.315 The Act requires cosmetics manufacturers to
report products that contain ingredients known or "reasonably
anticipated" to be human carcinogens to California's Division of
Environmental and Occupational Disease Control (Division), a
program within the state's Department of Public Health. 1  In stark
contrast to current federal regulations, the California Cosmetics Act
does not contain a loophole for "trade secret" or "fragrance"
ingredients. Manufacturers must still include ingredients that fall
into these categories in the ingredient lists they submit to the
Division. 317 Additionally, the Division can conduct investigations
into cosmetic products containing any ingredient of concern, and can
require manufacturers to submit any relevant health effects data and
studies, as well as information on the , sales, product use, and
ingredients' chemical concentrations. 8
If the Division finds a product to be in violation of the California
Safe Cosmetics Act, the manufacturer may face monetary fines or
even jail time.319 A person convicted of violating any section of the
Act could be subject to imprisonent for up to one year in county jail
and fines of up to $1,000.320 If the conviction is a result of removing,
selling or disposing of an embargoed cosmetic, or if the violation
315. Cal. Health & Safety Code § 111791 (2006); S. 484th Leg., Reg. Sess. (Cal.
2005).
316. Cal. Health & Safety Code § 111791.5(b)(4) (2006).
317. Id 111792(a) (2006).
318. Id § 111792.5 (2006).
319. Id § 111825 (2006).
320. Id 111825(a) (2006).
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occurred after a previous conviction under the Act, the fine can
increase to $10,000.321
Since the Act took effect in 2007, the California Safe Cosmetics
Program (CSCP), the California Attorney General's Office, and the
California Department of Public Health have collaborated to ensure
compliance with the Act. The Division added five chemicals to the
CSCP Chemical List in 2010, which triggered mandatory reporting of
manufacturers who used one of them in a cosmetic product. 322 On
April 28, 2010, the California Attorney General's Office and the
Department of Public Health sent a joint letter to over 7,000
manufacturers in violation of the Act for not providing notice
disclosing the presence of listed chemicals in their products.323 The
CSCP has also worked to make the required reporting easier for
cosmetics manufacturers, and in 2011 re-launched their online
reporting system with "significant improvements." 324
The California Safe Cosmetics Act also attempts to facilitate the
FDA's regulation of cosmetics.325 If the Division determines that a
product contains an ingredient that the Cosmetic Ingredient Review
panel has found is not safe for that specific use, it refers the findings
to the FDA for possible federal enforcement.326 As of yet, however,
California's more aggressive approach has not spurred any new
reforms at the federal level.327
321. Id. § I1 1825(b)-(c) (2006).
322. Bisphenol A (BPA), metam potassium, bromochloroacetic acid, cumene,
and diclofop-methyl were added to the CSCP Chemical List. Updated 2010 CSCP
Chemical List (2010), CALIFORNIA SAFE COSMETICS PROGRAM,
http://"'www.cdph.ca.gov programs/cosmetics/Pages/New.aspxgchemlist (last visited
Feb. 16, 2011).
323. Id.
324. Changes to Colors, Scents, Flavors, Kits and Collections reporting (Dec.
30, 2010), CALIFORNIA SAFE COSMETICS PROGRAM, http://www.cdph.ca.gov/
programs/cosmetics/Pages/New.aspxdcolors (last visited Jun. 2, 2011);
CALIFORNIA SAFE COSMETICS PROGRAM, INSTRUCTIONS FOR THE CALIFORNIA
SAFE COSMETICS PROGRAM REPORTING SYSTEM (Dec. 30, 2010),
http://".,,'www.cdph.ca.gov programs/cosmetics/Documents/
Reportinglnstructions.pdf.
325. Cal. Health & Safety Code § 111792.5(c) (2006).
326. Id. § 111793.5(c) (2006).
327. See supra Part II.B. (discussing lack of reform of cosmetics regulation at
the federal level).
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The CSCP is an important step forward in the fight for safe
cosmetics. Not only has the state moved to bring thousands of
manufacturers into compliance with the Act, but it also is now
pursuing violators in court; in April 2011, the state filed a
preliminary injunction against the manufacturer of Brazilian
Blowout. 328 The cosmetics industry lobbied heavily against the Act,
329 yet the success of the program nullifies many arguments pressed
by opponents and should help to encourage the passage of similar
statutes in other states. The ability of California, the most populous
state in the country,330 to raise awareness of dangerous products and
to remove them from the market should serve as encouragement that
a similar system could be implemented in New York State.
Following the successful passage of the California Safe Cosmetics
Act, other states have attempted to enact similar legislation.
Although no state legislature has yet succeeded, it is informative to
examine two bills introduced since 2005.
In 2007, legislators in Washington State introduced the
Washington Safe Cosmetics Act.331 The Act would require
manufacturers with over $1 million in sales to disclose health data
and all ingredients known or suspected to cause cancer or
reproductive damage, including "trade secret" ingredients, and would
allow the state to investigate products suspected of containing
dangerous ingredients.332 The bill did not emerge from committee
and has not been reintroduced since 2008.33
328. See supra Part I.A. (discussing recent events surrounding the discovery of
formaldehyde in Brazilian Blowout); see also Andrea Nagel, California to Rule on
Brazilian Blowout, WOMEN'S WEAR DAILY (Apr. 13, 2011), available at
http:// x www.wwd.com/beauty-industry-news/calif-to-rule-on-brazilian-blowout-
3581574.
329. According to state records, Proctor & Gamble paid Sacramento lobbyists
more than $260,000 and the Cosmetics and Fragrance Trade Association spent half
a million dollars in 2005 opposing the California Safe Cosmetics Act and other
environmental health legislation in California. Malkan, supra note 8, at 90.
330. California - 2010 Demographic Profile, U.S. CENSUS BUREAU (Sept. 1,
2011), http://www.census.gov popfinder.
331. Lisa Stiffler, State Mulls Cosmetic Safety Bill Based on California Measure,
SEATTLE PosT INTELLIGENCER, Feb. 20, 2007, at BI.
332. Id.
333. Washington Safe Cosmetics Act, H.B. 2166, 60th Leg., Reg. Sess. (2007-
2008).
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State legislators introduced the Colorado Safe Personal Care
Products Act in 2010.334 The Act proposed more aggressive
consequences than the California Safe Cosmetics Act for products
containing potentially dangerous chemicals. Under the bill, if a
product contains a chemical identified by an "authoritative body" to
cause cancer or reproductive toxicity, its sale would be banned.33 1
The proposed Colorado bill would adopt the findings of the
Environmental Protection Agency, the FDA, the National Institute
for Occupational Safety and Health, or the International Agency for
Research on Cancer to determine if a chemical causes cancer or
reproductive toxicity.3 3 1 In March 2010, the Judiciary Committee
voted the Act down.337
B. New Y ork State Legislation
In February 2011, Democrat Michelle Titus introduced the Safe
Cosmetics Act of 2011 in the New York Assembly.3 8 The bill
requires cosmetics manufacturers to compile an accurate list of their
cosmetic products that contain any chemical ingredient identified by
any of four scientific sources to cause cancer or express reproductive
toxicity. 339  These sources are: (1) the United States National
Toxicology Report,340 (2) the International Agency for Research on
Cancer,3 4' (3) the EPA's carcinogenicity list, 342 and (4) the National
334. Colorado Safe Personal Care Products Act, H.B. 10-1248, 67th Gen.
Assemb., 2nd Reg. Sess. (2010).
335. Id.
336. Id.
337. Alicia Ault, Safe Cosmetics Bill Defeated, SKIN AND ALLERGY NEWS, April
1, 2010, at 30.
338. Safe Cosmetics Act of 2011, A. 5059, 233rd Leg., Reg. Sess. (N.Y. 2011)
(sponsored by Titus, Democrat, 31st District, Queens).
339. Id.
340. Id. The United States National Toxicology report identifies known
carcinogens and materials reasonably anticipated to cause cancer. Id.
341. Under the proposed Act, cosmetics manufacturers would be required to list
a substance that receives a carcinogenicity designation of group 1, 2A, or 2B by the
International Agency for Research on Cancer. Id.
342. Id. The Safe Cosmetics Act requires that manufacturers list any substance
that receives a carcinogenicity designation of group A, B1, or B2 on the EPA's
carcinogenicity list; see also supra note 70 (describing in greater detail the EPA's
standards of carcinogenicity).
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Toxicology Program's Center for the Evaluation of Risks to Human
Reproduction.3 4 3 The bill would designate the state Department of
Health as the "authoritative body" to review cosmetic products that
contain chemicals identified as causing cancer or reproductive
toxicity. 344
The Safe Cosmetics Act would also empower the New York State
Department of Health to investigate cosmetic products that contain
chemicals identified as causing cancer or expressing reproductive
toxicity or other ingredients "of concern" to the Department. 345
During the course of an investigation, the Department could review
available health effects, data and studies, worksite health hazard
evaluations, and epidemiological studies to deternine the health
effects of exposures to chemicals. The Department would be able to
require manufacturers to submit relevant health data, chemical
concentration information, and sales data.346  If the Department
determines that an ingredient in a cosmetic product is potentially
toxic, it would refer the results of its investigation to the State's
Occupational Safety and Health Hazard Abatement Board.347 Within
180 days, the Board would be required to develop and present one or
more proposed occupational health standards to the State's
Department of Labor, unless the Board affirmatively determines that
a standard is not necessary.
To ensure the public disclosure of some of the most harmful
chemicals, separate legislation proposed in the Assembly in 2009
would have required the labeling of cosmetic products containing D4
or D5 siloxanes, phthalates, triclosan, parabens, or synthetic chemical
343. Manufacturers must report any substance that has been determined, by
clear evidence, to present a risk of adverse developmental or reproductive toxicity
effects by experts at the Center for the Evaluation of Risks to Human
Reproduction. Safe Cosmetics Act of 2011, A. 5059, 233rd Leg., Reg. Sess. (N.Y.
2011) (sponsored by Titus, Democrat, 31st District, Queens).
344. The Department of Health's review "may include, but not be limited to, a
review of health effects, data and studies, worksite health evaluations,
epidemiological studies to determine the health effects of exposures to chemicals."
Id.
345. Id. § 2252(1).
346. Id. § 2252(4).
347. Id. § 2253(1).
348. Id. § 2253(2).
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musks.349 A third bill proposed in 2009 would have directed the
state's Department of Health to promulgate regulations concerning
the use of chemicals in nail salons. 350 The bill would have required
salons to display signs in a prominent place identifying the chemicals
that are used and describing the potential health and safety hazards
associated with them. 51  These bills died with the end of the
legislative session on December 31, 2010.352
Despite the failure of legislation regarding chemical disclosure in
prior sessions, there is reason to believe the Safe Cosmetics Act of
2011 may progress out of the Assembly's Health Committee this
year. As 2011 is a non-election year, state legislators may ha-ve more
time and resources to focus on legislative efforts. In addition, given
the recent media attention to the issue of cosmetics safety, 3 the time
for an advocacy campaign pursuing legislative reform at the state
level may be ripe.
C. Newi' York City Government
1. New York City Council
The New York City Council derives its authority to govern from
the New York State Constitution and the New York City Charter. 354
The state constitution, as amended in 1963, contains a "Bill of Rights
for Local Governments," also known as the "home rule" provision,
349. A. 6892, 232nd Leg., Reg. Sess. (N.Y. 2009) (sponsored by Meng). On
January 6, 2010, this bill was referred to the Consumer Affairs and Protection
Committee, where it died with the end of the last session.
350. A. 2104, 232nd Leg., Reg. Sess. (N.Y. 2009) (sponsored by Benjamin); S.
3323, 232nd Leg., Reg. Sess. (N.Y. 2009) (by Stewart-Cousins). The bill was
referred to the Economic Development Committee in the Assembly in January,
2010. The Senate version of the bill was referred to the Consumer Protection
Committee in March, 2009, where it died with the end of the last session.
3 5 1. Id.
352. See New York State Rules of Assembly § 2(f) (2010); Rules of the Senate
of the State of New York, Rule IV § 8 (2010).
353. See supra notes 9-26 and accompanying text.
354. N.Y. Const. art. IX, § 1; N.Y. City Charter (2009), available at
http://xwww.nyc.gov/html/charter downloads/pdf/citycharter2009.pdf (last visited
Feb. 16, 2011).
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which is further supported by several state statutes.355  Under the
"home rule" provision, local governments may exercise powers
enumerated to them by state statutes, as well as adopt laws within ten
specific subject areas3 6  The subject area most relevant to the
regulation of cosmetics is "the government, protection, order,
conduct, safety, health and well-being of persons or property" within
the local jurisdiction.357
The New York City Charter vests the legislative power of the city
in the Council.358 The City Council has the power to adopt local laws
it deems appropriate, so long as they are not inconsistent with the
City Charter, the United States or New York State Constitutions, or
state or federal laws .35 The current iteration of the New York City
Council has thirty-seven committees and five subcommittees. 360 If a
bill involving the regulation of cosmetics were introduced, it most
355. N.Y. Const. art. IX, § 1; N.Y. Mun. Home Rule Law § 51 (McKinney
2010); N.Y. Stat. Local Govt's Law § 20 (McKinney 2010). Local governments are
permitted to have a legislative body with the power to pass laws pursuant to the
state's constitution. N.Y. Const. art. IX, § 1(a), (b), § 2(b).
356. N.Y. Const. art. IX, § 2(c).
357. N.Y. Const. art. IX, § 2(c)(10). The remaining nine subject areas are:
powers, duties, qualifications, number, mode of selection and removal, terms of
office, compensation, hours of work, protection, welfare and safety of its officers
and employees; in the case of a city, town or village, the membership and
composition of its legislative body; transaction of its business; incurring of its
obligations, except that local laws relating to financing by the issuance of
evidences of indebtedness by such local government shall be consistent with laws
enacted by the legislature; presentation, ascertainment and discharge of claims
against it; acquisition, care, management and use of its highways, roads, streets,
avenues and property; acquisition of its transit facilities and the ownership and
operation thereof; levy, collection and administration of local taxes authorized by
the legislature and of assessments for local improvements; and wages or salaries,
the hours of work or labor, and the protection, welfare and safety of persons
employed by any contractor or sub-contractor performing work, labor or services
for it. N.Y. Const. art. IX, § 2(c)(1)-(9).
358. N.Y. City Charter, § 21.
359. N.Y. City Charter, § 28.
360. Conmittees, NEW YORK CITY COUNCIL, http://legistar.council.nyc.gov/
Departments.aspx (last visited October 9, 2010).
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likely would be referred for consideration to the committees on
Environmental Protection, Health, or Women's Issues.36 1
The New York City Council has not considered legislation directly
pertaining to cosmetics regulation since at least 1998.362 The most
relevant legislation since that time was bills that involved the
regulation of nail salons.363  Although the Committee on Health
considered these bills, none became law. 364
The New York City Council has previously signaled its willingness
to try to improve public health through bans of smoking in public
places365 and parks,366 and has expanded its housing program to
target health violations such as mold, asthma, insects, and mice.367
The City Council may thus be amenable to considering legislation to
protect consumers from dangerous ingredients in cosmetics.
2. Mayor's Office
Although the New York City Charter vests the City Council with
legislative power over the city,368 it also grants the Mayor a number
of general powers. 369  With over eight million residents370 the
population of New York City is larger than that of all but eleven
361. Cosmetic regulation could fall under the purview of numerous committees,
due to public health and environment implications, as well as the disparate impact
on women, who typically have a greater exposure to cosmetics.
362. The New York City Council website only makes available the text of bills
considered since 1998. NEW YORK CITY COUNCIL, LEGISLATIVE RESEARCH
CENTER, http://legistar.council.nyc.gov/Legislation.aspx (last visited Dec. 21,
2011).
363. Int. 1096-2009, N.Y.C. Council, Session 2010-2013 (2009); Int. 0245-2010,
N.Y.C.
Council, Session 2010-2013 (2010).
364. New York City Council Int. 1096-2009, Int. 0245-2010.
365. New York City, N.Y., Local Law No. 47 Int. 256-A (2002).
366. New York City, N.Y., Local Law No. 11 Int. 0332-A (2011).
367. New York City, N.Y., Local Law No. 29 Int. 436-A (2010).
368. N.Y. City Charter, § 21.
369. Id. § 8.
370. UNITED STATES CENSUS BUREAU, POPULATION DIVISION, TABLE 1:
ANNUAL ESTIMATES OF THE POPULATION FOR INCORPORATED PLACES OVER
100,000, RANKED BY JULY 1, 2009 POPULATION: APRIL 1, 2000 To JULY 1, 2009,
available at http:xx/www. census.gov popest/cities/SUB-EST2009.html (last visited
Apr. 11, 2011).
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states. The government of New York City contains a number of
specialized departments and agencies that befit the complexities that
come with serving such a large population. The City Charter
empowers the Mayor to reorganize, create or disband these
agencies,372 and generally to establish policy and procedures to
"achieve effective and efficient functioning of management of city
government." 373 Mayor Michael Bloomberg has aggressively tested
the limits of the powers of the New York City Mayor. During his
second term in office, Bloomberg embarked upon a campaign to
improve public health by banning most artificial trans-fats in
prepared food and requiring restaurants to post calorie information on
menus.374 Bloomberg's use of mayoral agencies to enact a calorie
posting requirement, and his subsequent legal victories affirning his
actions' validity, illustrate the potential for using alternatives to
legislation to alert consumers of the possible dangers lurking in
cosmetics.
In December 2006, the New York City Board of Health (Board),
under the authority of the City's Department of Health and Mental
Hygiene (DOHMH), instituted a regulation requiring any restaurant
that voluntarily published calorie information to include that
information on their menus and menu boards. 37 The New York
State Restaurant Association (NYSRA) brought suit against the
Board, arguing that the regulation was preempted by the Nutrition
Labeling and Education Act of 1990 (NLEA), a section of the
371. U. S. CENSUS BUREAU, 2010 CENSUS ESTIMALTES (2011), available at
http://www.census.gov popest/eval-estimates/eval-est2010.html (last visited Apr.
11,2011).
372. N.Y. City Charter, § 8(a). Each January, the Mayor must submit a
management report to the City Council concerning the performance of each city
agency relative to established performance goals. Id. § 12.
373. The structure of the executive branch of the New York City government is
similar to the federal government's use of administrative agencies to promulgate
regulations and rules in specialized areas to ensure an efficiently functioning
nation. Id. § 11(a).
374. Thomas J. Lueck, Public Speaks on Plan to Limit Trans Fats, Adostly in
Favor, N.Y. TIMES, Oct. 31, 2006, at B2.
375. See Ray Rivera, City Council May Rewrite Calorie Rules, N.Y. TIMES,
February 26, 2007, at BI; N.Y. City Health Code § 81.50.
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Federal FDCA.376 Under the Supremacy Clause of the United States
Constitution,"7 federal law preempts any conflicting state law.
However, "because the States are independent sovereigns in our
federal system, [courts] have long presumed that Congress does not
cavalierly pre-empt state-law causes of action."379 Particularly "[i]n
areas of traditional state regulation, [courts] assume that a federal
statute has not supplanted state law unless Congress has made such
an intention 'clear and manifest.'" 380
Congress passed the NLEA "to clarify and to strengthen the Food
and Drug Administration's legal authority to require nutrition
labeling on foods, and to establish the circumstances under which
claims may be made about nutrients in foods." 381 hen NYRSA
challenged the Board's regulation, the federal district court found that
because the regulation involved health, specifically combating rising
obesity, "the presumption against preemption applies, indeed, [it]
stands at its strongest."382 The court further noted that public health
376. New York State Restaurant Ass'n v. New York City Bd. of Health (NYSK4
1), 509 F.Supp.2d 351, 354 (S.D.N.Y. 2007).
377. U.S. Const. art. VI, cl. 2.
378. See Cipollone v. Liggett Group, Inc., 505 U.S. 504, 516, 112 S.Ct. 2608
(1992) ("Article VI of the Constitution provides that the laws of the United States
"shall be the supreme Law of the Land....any Thing in the Constitution or Laws of
any state to the Contrary notwithstanding... it has been settled that state law that
conflicts with federal law is without effect.") (internal citations and quotation
marks omitted).
379. NIESR4 I, 509 F.Supp.2d at 355, (citing Medtronic, Inc. v. Lohr, 518 U.S.
470, 485, 116 S.Ct. 2240 (1996)).
380. Bates v. Dow Agrosciences L.L.C., 544 U.S. 431, 449 (2005) (quoting N.Y.
State Conference of Blue Cross & Blue Shield Plans v. Travelers Ins. Co., 514 U.S.
645, 655, 115 S.Ct. 1671, 131 L.Ed.2d 695 (1995)). Where "Congress has
legislated ... in a field which the States have traditionally occupied, we start with
the assumption that the historic police powers of the States were not to be
superseded by the Federal Act unless that was the clear and manifest purpose of
Congress." Medtronic, Inc., 518 U.S. at 485 (citations and internal quotation marks
omitted).
381. H.R. Rep. No. 101-538, at 7 (1990), reprinted in 1990 U.S.C.C.A.N. 3336,
3337.
382. NIESK4 I, 509 F.Supp.2d at 355, (citing Desiano v. Warner-Lambert & Co.,
467 F.3d 85, 94 (2d Cir. 2007)).
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is prime example of a power traditionally reserved to the states.383
Notwithstanding this general finding, the court ruled that because the
Board's regulation applied only to restaurants that had voluntarily
provided calorie information, it imposed obligations that conflict
with than the federal regulations implementing NLEA and therefore
was pre-empted.384
The court left the door open for a future regulation to meet
preemption standards. The court noted in dicta that the city would be
able to enact mandatory calorie disclosures of all restaurants under a
provision in NLEA's separate misbranding section. 385  Under a
mandatory disclosure regulation, the court stated, opponents could
not successfully argue "that mandated disclosures are more properly
considered the regulation of voluntary claims" under NLEA.386
On January 22, 2008, the Board repealed the original calorie
disclosure regulation and issued a modified version.387 The new
version of Regulation 81.50 requires all chain restaurants with fifteen
or more establishments nationally to display calorie information on
menus and menu boards.388  NYSRA again challenged the rule,
arguing that even as amended, it was preempted by FDA
regulations. 389 The city argued that NLEA did not preempt the new
regulation "because [NLEA] explicitly leaves to state and local
governments the power to impose mandatory nutrition labeling by
restaurants." 90
383. Id. (citing Med. Soc'y of the State of N.Y. v. Cuomo, 976 F.2d 812, 816 (2d
Cir. 1992)) ("The regulation of public health and the cost of medical care are
virtual paradigms of matters traditionally within the police powers of the state.").
384. V1SRA I, 509 F.Supp. 2d 351 at 361-63.
385. Id.; 21 U.S.C.A. § 343 (West 2010).
386. Id. § 363.
387. See DEP'T OF HEALTH AND MENTAL HYGIENE BD. OF HEALTH, NOTICE OF
ADOPTION OF A RESOLUTION To REPEAL AND REENACT § 81.50 OF THE NEW YORK
CITY HEALTH CODE (Jan. 22, 2008).
388. New York City Health Code § 81.50; Sewell Chan, "Court Upholds the
City's Rule Requiring Some Restaurants to Post Calorie Counts," N.Y. TIMES,
February 18, 2009, at A24.
389. See Chan, supra note 388.
390. New York State Restaurant Ass'n v. New York City Bd. of Health (NY.SRA
II), 556 F.3d 114, 122 (2d Cir. 2009).
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The Second Circuit Court of Appeals rejected NYSRA's challenge
and affirmed the district court's ruling upholding the regulation.391
The main issue for the court was whether the regulation's mandatory
quantitative calorie disclosures are "claims" (such as statements like
"low in fat" or "high in fiber"), which are preempted, or are
"nutrition information," which are not preempted. 92 Adopting a test
the FDA set forth in an amicus brief, the court detennined that
federal law did not preempt the regulation.393 The court also used a
rational basis test to reject NYSRA's claim that the regulation
infringed upon their members' First Amendment rights by
compelling commercial speech.394 The court found that New York
City "plainly demonstrated a reasonable relationship between the
purpose (of the regulation) and the means employed to achieve that
purpose,"395 citing the city's campaign to fight obesity.396
3. Applicability to Cosmetics Regulation Reform
New York City's successful implementation of a calorie disclosure
requirement may yield meaningful lessons should the City seek to
require cosmetics ingredient disclosure. The starting point for this
analysis is the whether the FDCA would preempt such an effort.
Although the cosmetics chapter of the FDCA does contain a section
on misbranding, 397 it does not contain comprehensive sections likely
to preempt city action in this area.
The FDCA forbids a state or local government from establishing a
requirement for labeling or packaging "that is different from or in
addition to, or that is otherwise not identical with, a requirement
specifically applicable to a particular cosmetic or class of cosmetics"
under the Act itself.398  This bar against establishing label
requirements that contradict the FDCA applies to two other federal
statutes, the Fair Packaging and Labeling Act (FPLA) and the Poison
Prevention Packaging Act, because the FDCA controls in all matters
391. NYSK4 II, 556 F.3d 114 at 117-118.
392. Id. at 123.
393. Id. at 130-31.
394. Id. 133-34.
395. Id. 134.
396. Id.
397. 21 U.S.C.A. § 362.
398. Id. § 379s(a).
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regarding the regulation of cosmetics, even though other statutes may
seem applicable on their face.399 However, the FDA may provide a
state or locality with an exemption from this FDCA provision if the
state or local governnent's action: 1) protects an important public
interest that would otherwise be unprotected; 2) would not cause a
cosmetic to be in violation of any applicable requirement or
prohibition under the FDCA; or 3) would not unduly burden
interstate commerce. 40 0
The FPLA also provides guidance regarding preemption. The
statute contains a provision articulating Congress's "express intent"
to supersede all state and local laws pertaining to packages' net
quantity labeling that are "less stringent than or require information
different from the requirements of [the Act] or regulations
promulgated pursuant thereto .40 Therefore, it would appear that
more stringent requirements, such as those requiring the disclosure of
ingredients in fragrance or trade secret chemicals, would be
permitted.
A hypothetical regulation concerning cosmetics proposed by the
Department of Health and Mental Hygiene (DOHMH) would fall
under the FDA's exemption test.40 2 While the DOHMH has not yet
proposed regulations concerning cosmetics, this Note imagines such
a regulation that would require disclosure of ingredients that are
possible or known carcinogens, and would require warning labels on
cosmetics containing dangerous ingredients.403 Under the first prong
FDA's exemption standard, the FDA would determine if the
regulation protected an important public interest that would otherwise
not be protected.404 The federal governrnent provides little protection
for consumers from dangerous cosmetics due to the FDA's minimal
oversight over cosmetics and the FDCA's loopholes.405  This
hypothetical City regulation would provide New York consumers
with protection that is unavailable through the federal government.
399. Id.
400. Id. § 379s(b).
401. 15 U.S.C.A. § 1461.
402. See supra Part IV.B.2 (discussing the FDA's exemption test).
403. This hypothetical regulation is largely based upon the requirements of
California and the EU's cosmetics regulation statutes.
404. 21 U.S.C.A. § 379s(b).
405. See supra Part II (discussing federal regulations controlling cosmetics).
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Additionally, in the absence of the passage of the Safe Cosmetics of
2011 by the New York Legislature, the state is likewise unable to
provide consumer protection. 0 6
The second prong of the FDA's test requires that the regulation not
cause a cosmetic to violate or contradict any requirements of the
FDCA.407  Under the hypothetical regulation, no provision of the
FDCA would be violated or in any way comprised. The regulation
would merely enhance the requirements under the FDCA and in no
way would subvert its purpose of protecting public health.408
Finally, the FDA would examine the regulation's impact on
interstate commerce.409 While New York City's population of over 8
million 410 and its corresponding purchasing power would certainly
have an impact on interstate commerce, the regulation would not
impose the "undue burden" that is prohibited by the FDA.411 Perhaps
the best evidence in support of the regulation under this prong is the
California Safe Cosmetics Act.412  The FDA did not challenge
California's system of cosmetics regulation, which affects a far
greater number of products413 and therefore has a greater impact on
interstate commerce, than a regulation affecting only New York City.
406. See supra Part IV.B. (discussing the New York Safe Cosmetics Act of
2011).
407. For an example of a regulation causing a violation of a federal statute, see
supra Part IV.C.2 (discussing NYRSA 1); 21 U.S.C.A. § 379s(b).
408. As New York City did not preemptively seek permission from the FDA
before implementing calorie labeling information, it is clearly not a requirement,
but support from the agency would certainly help to bolster the City's case in any
legal or political challenges to such a cosmetics regulation, as demonstrated in New
York State Restaurant Ass'n v. New York City Bd. of Health (NYISR4 11), 556 F.3d
114, 122 (2d Cir. 2009).
409. 21 U.S.C.A. § 379s(b).
410. New York City - 2010 Demographic Profile, U.S. CENSUS BUREAU,
http://xwww.census.gov popfmder/ (last visited Dec. 21, 2011).
411. FDA exempt a requirement for labeling or packaging that "would not
unduly burden interstate commerce." 21 U.S.C.A. § 379s(b).
412. See supra Part IV.A. (discussing the California Safe Cosmetics Act).
413. The Califbrnia Safe Cosmetics Act requires mandatory reporting of
cosmetics that contain any of the 791 ingredients included on the Act's Chemical
List, whereas the FDCA does not contain any similar provision. CAL. DEP i.
PU BLC HEALIH 2010 CSCP CHEMICAL Lisi (Dec. 1, 2010).
hatp://www.cdph.cagov/prorams/cosmitics/Documents/chemlist pdf; see supa,
Part II!A.2 (discussing the iiits of the FDCA).
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It therefore seems likely that the FDA would grant this hypothetical
regulation an exemption under the FDCA.
Although the legality of such a regulatory mandate would be
analyzed under this federal rubric, the JNJRSA cases, which assess the
legality of mandatory calorie disclosure under the Nutrition Labeling
and Education Act (NLEA), also provide a number of illuminating
legal principals. First, in NYSRA I, the district court found that when
health is concerned, the presumption against preemption "stands at its
strongest." 414 There is ample evidence that many cosmetics contain
ingredients known to cause cancers or reproductive toxicity, 4 15 and
informing consumers of this certainly benefits public health. It
would likely be difficult for an opponent to overcome this
presumption and establish that a regulation requiring disclosure
would not concern health.
Second, critics of cosmetics labeling regulations would almost
certainly raise First Amendment claims, similar to those the courts
evaluated in NYRSA I and II. If a court applied a rational basis test,
as it did in the NYSRA cases,416 the city could cite the need to inform
consumers and reduce instances of cancer, thereby creating a rational
relationship between the purpose of regulation and the means
employed. This should be more than sufficient to overcome a First
Amendment challenge.
V. CONCLUSION AND RECOMMENDATIONS
A. Legislative and Regulatory Reform
The history of cosmetic regulation is riddled with hard-fought
battles, and there is no indication that a new campaign for reform will
be met with any less opposition.417 The results of the 2010
Congressional elections may further reduce the likelihood of passage
414. See New York State Restaurant Ass'n v. New York City Bd. of Health
(vYSRA 1), 509 F.Supp.2d 351, 355 (S.D.N.Y. 2007), (citing Medtronic, Inc. v.
Lohr, 518 U.S. 470, 485 (1996)); see supra Part IV.C.2 (discussing the
presumption against preemption in health regulations).
415. See supra Part I.B. (discussing certain chemicals used in cosmetics and their
impact on the human body).
416. See supra Part IV.C.2 (discussing the decisions in VRSA l and VRSA II).
417. See supra Part II.A.1 (discussing the history of the passage of the Food,
Drug and Cosmetic Act).
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of TSCA and FDCA reforn. 418  Though the Democratic Party
maintained control of the Senate, their considerable loses in the
House of Representatives make the possibility of a bill passing
without some intervening event that puts tremendous pressure on
legislators seem highly unlikely. 419
If political circumstances preclude the possibility of success at the
federal level, New York's proponents of cosmetics regulation reform
activists can pursue passage of a bill in the State Legislature.
Although Republicans regained control of the New York State Senate
and now hold 32 of 62 seats, 420 Democrats still maintain a strong
majority in the New York Assembly, and the possibility of building
support in the State Legislature should not be completely
* * 421dismissed. Proposed legislation promoting safe cosmetics already
exists in the Senate and Assembly, but thus far has not gained
-422traction.
In the absence of reform at the state level, local government may
wish to act to better protect consumers from possibly dangerous
cosmetics. The New York City Council could introduce legislation
requiring warning labels or disclosure of the chemicals contained in
cosmetics. Regulations could also be effective. The New York City
Mayor's Office and the Department of Health and Mental Hygiene
arguably has the power to pass regulations aimed at allowing
consumers to make more informed decisions when purchasing
cosmetics.
418. While the issue of cosmetics regulation is not necessarily a partisan debate,
all sponsors and co-sponsors of legislation intended to reform the FDCA and
TSCA are members of the Democratic Party. See EUROPEAN COMMISSION
ENVIRONMENT DIRECTORATE GENERAL, supra note 259.
419. Id.
420. Senators, NEW YORK STATE SENATE, http://xwww.nysenate.gov senators.
421. As with federal legislation, all sponsors, co-sponsors and multi-sponsors of
cosmetics regulation reform bills in New York State are members of the
Democratic Party. See supra Part. IV.B (discussing the Safe Cosmetics Act of
2011).
422. See supra Part IV.B (discussing the Safe Cosmetics Act of 2009 and the
Safe Cosmetics Act of 2011).
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B. Community Education
Community education is an essential component of a campaign to
reform cosmetics regulation. Public awareness of the deficiencies in
the current statutory scheme is essential for developing a base of
support to enact refonn legislation. In addition to educating the
public at large about the current regulatory structure and proposed
reforms, community education programs could focus on users of
ethnic cosmetics, and at the same time garner helpful feedback on
attitudes toward products' use. Past consumer organizing
campaigns, such as those to eliminate phthalates from nail polish,
were successful in pressuring cosmetics companies to change
423formulas and discontinue use of dangerous ingredients. A
community education program could go further to encourage
manufacturers to take the lead and offer healthier products.
Demonstrating the demand for safer products could facilitate a
dialogue between cosmetics consumers and manufacturers, perhaps
ultimately leading to the voluntarily termination of dangerous
ingredient use.
A boycott of particular products or companies could prove
successful if more moderate means fail. Ultimately, the cosmetics
industry is compromised of for-profit corporations that are primarily
concerned with sales and profits. If reformers are not able to effect
change through cooperation or legislation, the use of boycotts and
media outreach campaigns could be an extremely effective
technique. 424 Even if sales are not significantly affected, boycotts
could lead to increased media attention and cornunity education, as
well as increased pressure on manufacturers and legislators.
Overhauling the cosmetics regulation regime in the United States
will not be easy or quick. Nonetheless, the adoption of the
precautionary principal is essential to protecting and educating
consumers. For decades, the cosmetics industry has been allowed to
decide for itself what is safe while consumers, who are often
uninformed or misinformed, bear the risk of using possibly harmful
423. See supra Part I.C (discussing removal of dibuty1 phthalate from nail polish
in the United States and Europe).
424. See supra text accompanying note 54 (discussing the decision of cosmetic
manufacturers to remove DBP from nail polish).
425. See Katz, supra note 245 (discussing the precautionary principle).
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products. It is unacceptable that the federal government wait until
harm occurs before taking action, particularly when California and
Europe operate successful cosmetic regulation programs. Until
Congress is willing to reform the FDCA and the TSCA, states and
local governments should take it upon themselves to require
increased oversight of cosmetics.
